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“It is not possible for our knowing to go beyond 
what is strictly necessary for the preservation of 
life. 
  The morphology shows us that the senses, the 
nerves and the brain develop proportionally to the 
difficulty of feeding.” 
 
F.W. NIETZSCHE 
 
 
 
 
   Index 
 3 
 
I. BACKGROUND____________________________________________________5 
 
II. MANUSCRIPT INCLUDED__________________________________________8 
 
III. LIPID METABOLISM ______________________________________________ 9 
 
IV. CLA BIOSYNTHESIS _______________________________________________13     
4.1 Rumen origin  
4.2 Tissue and milk origin  
4.3 Synthesis in human  
 
V. CLA DIETARY SOURCES___________________________________________18 
5.1 Ruminant products  
5.2 Monogastric products . 
 
VI. FACTORS AFFECTING CLA ________________________________________ 21 
6.1 Diet . 
6.2 Breed 
6.3 Starting milk 
6.4 Microbial cultures 
6.5 Cheese processing 
 
VII. CLA HEALTHY PROPERTIES ______________________________________  28 
7.1 Anti-carcinogenesis effects 
7.2 Anti-aterosclerotic effects 
7.3 Anti-adipogenic effects 
7.4 Effect against Insulin resistance 
7.5 Effect against Inflammation response 
7.6 Bone health 
 
VIII. CLA ANALYSIS____________________________________________________ 43 
8.1 Lipid estraction (Folch) 
8.2 Methylation 
8.3 Chromatogram 
 
IX. MANUSCRIPT 1____________________________________________________47 
Dairy Food And Health 
 
 
 
X. MANUSCRIPT 2____________________________________________________66  
Conjugated linoleic acid isomer (cis9,trans11 and trans10,cis12) content in cheeses 
from italian large-scale retail trade 
   Index 
 4 
 
XI. MANUSCRIPT 3____________________________________________________76 
Contents of conjugated linoleic acid (CLA) isomers (cis9,trans11 and trans10,cis12) 
in ruminant and non-ruminant meats available in the Italian market 
 
 
XII. MANUSCRIPT 4____________________________________________________89  
Estimation of c9,t11 and t10,c12 conjugated linoleic acid isomers intake in a cohort 
of healthy students in Italy 
 
XIII. MANUSCRIPT 5___________________________________________________110 
Breed and dietary linseed and protected fish oil affected gene expression in 
longissimus dorsi muscle of beef 
 
XIV. GENERAL CONCLUSIONS_________________________________________134 
 
 
XV. REFERENCES_____________________________________________________137 
 
 
 
 
 
 
Background 
 5 
 
 
I. BACKGROUND 
 
CLA refers to a group of positional and geometrical isomers of linoleic acid (LA; 
cis9,cis12 octadecadienoic acid) with conjugated double bonds. These fatty acids are 
naturally present in ruminant derived products, thus dairy foods and meat are the main 
sources. CLA importance is related mainly to the healthy properties of two isomers: 
cis9,trans11 (c9,t11) and trans10,cis12 (t10,c12) (Bhattacharya et al., 2006; Benjamin 
and Spener, 2009; Churruca et al., 2009; Stringer et al., 2010; Park et al., 2010; Raff et 
al., 2009). According to animal and cell culture experiments c9,t11 plays a protecting 
role against cancer and atherosclerosis (Bhattacharya et al., 2006), and can also 
attenuate insulin resistance (Taylor and Zahradka, 2004; Hong et al., 2009). 
t10,c12 can be mainly related to the increase in energy expenditure and fat oxidation, 
decrease of adipocyte size and inhibition of some enzymes of fatty acid metabolism 
and lipogenesis (Blankson et al., 2000; Bhattacharya et al., 2006). 
Moreover Stringer et al. (2010) showed that t10,c12 isomer prevents hepatic steatosis 
and higher levels of HDL, improves liver functions and attenuates inflammation. 
However, these findings are sometimes contrasting regarding the effects in vivo in 
humans. 
CLA isomers are synthesized by the ruminal bacteria as intermediates in the 
biohydrogenation of linoleic acid.  c9,t11 is also produced in tissues and in the 
mammary gland from the desaturation of vaccenic acid escaped from rumen and it is 
incorporated in tissue and milk lipids, (Bauman et al. 2001; Griinari and Bauman, 
1999). The c9,t11 isomer covers >90% of the CLA isomers in milk fat, while its 
proportion in beef fat is only 60-85% (Chin et al., 1992; Shanta et al., 1994; Parodi, 
1999).  
CLA content in cheese can be affected by several self-linked factors: feeding and 
starting milk, breeding type, cheese processing and microbial starter. Pasture feeding 
results in higher levels of CLA than indoor feeding, because of the high LA content of 
grass (Chilliard, 2001; Delagarde and Peyraud, 2002). Moreover a fibre rich diet is 
requested for the growth of some bacteria responsible for biohydrogenation such as B. 
fibrisolvens. Then, also the microflora responsible for cheese ripening is affected by 
Background 
 6 
the feeding regimen (Kim et al., 2009). In addition Dihman et al. (2007) indicated 
breed and stage of lactation as other animal-related factors influencing CLA content.  
The CLA content in dairy products could be also affected by the processing stages, but 
results are controversial (Bisig et al., 2007). Anyway it was clearly found that 
Lactobacilli and other microbial culture could increase CLA content during 
fermentation (Kim and Liu, 2002) and ripening (Jiang et al.,1998; Sieber et al.,2004). 
CLA content in meat can be affected by feeding as in dairy products (Dhiman et al., 
1997; Shanta et al., 1994; Stanton et al., 2003); then by muscle type (Rule et al., 2002) 
and by breed and animal age (Dannenberger et al, 2005; Nuernberg, 2005; Padre et al., 
2006).  
Therefore a strong variability among CLA concentrations in ruminant products can be 
found. 
A needed daily CLA intake could be defined, based on anticancer researches: Ip et al. 
(1994) reported the lowest effective CLA dose for reducing the cancer incidence 
extrapolated from animal data as 3g/day. Then Parish et al. (2003) showed that a range 
between 0.8-3 g/day CLA could be effective. Anyway the data available on human 
CLA intake are controversial. For example Mele et al. (2013) recently proposed that 
the evaluation of the CLA needed to exert its properties could not be obtained by the 
only extrapolation from animal data, but should be instead based on the study of 
different energy metabolism and other phisiological parameters. Moreover all the 
surveys conducted on CLA beneficial effects on humans were based on the CLA 
amount detected in blood, and it is not clear if this data is a single data or if it could 
cover a long period of time, as for ω3. Moreover there is a lack of studies on the 
ingestion of CLA, and most of the results on CLA effects on health are extrapolated 
from animals. 
In summary CLA could exert some healthy properties in relation to a needed daily 
intake, but, at our knowledge, no literature in Italy is currently available on the 
effective CLA amount in foods and on the relative intake in humans. 
Thus a quantification of c9,t11 and t10,c12 CLA isomers in foods available in Italy 
large retail-scale trade was performed, followed by an estimation of the isomers intake 
in a cohort of the Italian population by a food diary.  
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The following step of the research project, due to the very low concentration of CLA 
found in foods, investigated genetic factors affecting CLA in meat, in order to enhance 
its concentration for final consumers. 
Thus the aims of the present work were to estimate the effective CLA intake in Italy 
through a complete analisys of c9,t11 and t10,c12 concentrations in dairy and meat 
products commonly purchasable, and an evaluation on the genetic factors involved in 
CLA synthesis in meat. 
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II. MANUSCRIPT INCLUDED 
 
1. Dairy food and health 
Manuscript for “La qualità degli alimenti di origine animale e la salute umana”.  
Edited by Associazione per la Scienza e le Produzioni Animali (ASPA). Edizioni 
Fondazione Iniziative Zooprofilattiche, Brescia.  
In press 
 
 
2. Conjugated linoleic acid isomer (cis9,trans11 and trans10,cis12) content in 
cheeses from Italian large-scale retail trade 
Manuscript for: International Dairy Journal 
Published 
 
 
 
3. Survey on conjugated linoleic acid (CLA) content in monogastric and ruminant 
meats available in the Italian market 
Manuscript for: Italian Journal of Animal Science 
Submitted to journal 
 
 
 
4. Estimation of c9,t11 and t10,c12 conjugated linoleic acid isomers intake in a 
cohort of healthy students in Italy 
Manuscript for: Public Health and Nutrition 
 
 
 
 
5. Breed and dietary linseed and protected fish oil affected gene expression in 
longissimus dorsi muscle of beef 
Manuscript for: Lipids 
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III. LIPID METABOLISM 
 
Lipids are naturally occurring hydrophobic molecules exerting several biological 
functions. 
They can be divided in saponifiable lipids as triacylglycerols, phosphoacilglycerols, 
sphingolipids, glicolipids, waxes, and unsaponifiable as terpenes, steroides, 
prostaglandines and related compounds. 
Triacylglycerols in most of human tissues derive from glycerol esterification by three 
fatty acids (Fig 1). 
 
 
 
 
Fig.1. Triacylglycerols Synthesis 
 
 
 
 
 
 
 
The epitelial cells of small intestine produced triacylglycerols from the acylation of 
digestion derived monoacylglicerols. 
Triglycerides stand for the main energy source for our organism.  
They could be endogenously reassembled by the lipid digestion and/or they could be 
synthesized from carbohydrate excess. 
Gastric and pancreatic lipase digested lipids in stomach and small intestine producing 
free fatty acids and monoglycerols. Then they are absorbed in small intestine, 
assembled to produce triacylglycerols and incorporated in plasmatic lipoproteins 
(chylomicrons). By lymphatic vessels chylomicrons reach the systemic circulation 
through thoracic duct in superior vena cava. Then chylomicrons are shrunk in adipose 
tissue and scheletric muscles by a lipoproteic lipase. 
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Then free fatty acids can be used, while glycerol is released in blood and is picked up 
by the liver for glicolisys and gluconeogenesis. 
β-Oxidation 
ß-oxidation is the mitocondrial process involved in fatty acids disposal. Free fatty acids 
are activated as acyl-CoA and relased in cytosol. A carrier is needed for long chain 
acyl-CoA (12-18 C atoms) to pass through the mitocondrial membrane: the acyl-group 
is linked to carnitine, due to create acyl-carnitine, a complex able to enter. In 
mitocondria the acylic group is transferred again to A Coenzime. Short chain fatty 
acids are instead able to pass the mitocondrial membrane without any carrier and then 
they are activated in acyl-CoA. 
ß-oxidation is summarized below (Fig. 2): 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.  ß-oxidation 
 
From the estimation of ATP yield in oxidative phosphorilation, each ß-oxidation cycle 
release: 
- 1 Acetyl-Coa (corresponding to 10 ATP in tricarbossilic acid cycle), 
- 1 FADH2 (1,5 ATP), 
- 1 NADH (2,5 ATP), 
producing 14 ATP molecules. However 1 molecule of ATP is spent for fatty acid 
activation, thus 13 ATP molecules are produced. 
Fatty Acid Synthesis 
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The proces of fatty acid synthesis is outlined below (Fig. 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Fatty Acid Synthesis 
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Genes Involved  
 Directly involved in FA synthesis (Fig. 4) 
ACC (Acetyl-CoA Carboxylase)  
FAS (Fatty Acid Synthase) 
SCD o ∆9-Desaturase (Stearoyl-CoA Desaturase) 
∆6D (∆6-Desaturase)  
ELOVL5 (Fatty Acid Elongase 5) 
∆5D (∆5-Desaturase) 
 
Fig 4. Genes involved in FA synthesis 
 
Involved in lipid and other metabolic pathways related to CLA 
AMPKα (AMP-activated Protein Kinase α)---stimulation of hepatic FA oxydation and 
lipogenesis 
PPARγ (Peroxysome Proliferator-Activated Receptor γ)---nuclear receptor required for 
proper adipose tissue developement and implicated in the regulation of 
inflammation response 
PPARα (Peroxysome Proliferator-Activated Receptor α)---nuclear receptor affecting 
the FA synthesis and the inflammation response 
GLUT4 (Glucose Transporter 4)--- glucose uptake, related to insulin resistance 
ADIPOQ (adiponectin, C1Q and collagen domain containing)---involved in regulating 
glucose level and FA oxydation 
SREBP-1c (Sterol regulatory element-binding protein 1c)---enhances the transcription 
of the genes required for fatty acid synthesis and fatty acid elongation 
including FAS and SCD 
ADFP (adipose differentiation-related protein)---related to adypocite differentiation 
GPR43 (G-protein coupled receptor 43 or free fatty acid receptor)--- involved in lipid 
metabolism 
STAT5 (signal transducer and activator of transcription 5)---related to cell 
differentiation and inflammation 
CLA Biosynthesis 
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IV. CLA BIOSYNTHESIS  
 
CLA Isomers 
The acronym CLA refers to positional and geometrical isomers of linoleic acid (LA; 
cis9,cis12 octadecadienoic acid) with conjugated double bonds. Among them, 
cis9,trans11 and trans10,cis12 CLA have been recognised as the most biologically 
active isomers (Bhattacharya et al., 2006). 
Due to their origin as intermediates in the biohydrogenation performed by rumen 
microflora, CLA isomers are naturally present in ruminant derived products. 
In milk c9,t11 CLA is the predominant isomer, as it covers over 90% of all CLAs. 
(Parodi 1977, Chin et al., 1992) and in beef fat it covers over 75% of the CLA (Chin et 
al., 1992; McGuire et al., 1999; Yurawecz et al., 1999a). 
Sehat et al. (1998) identified the distribution of CLA isomers in cheese fat as c9, t11 
(78 to 84%), t7, c9 + t8, c10 (8 to 13%), t11, c13 (1 to 2%) and c12, t14. In addition 
Fritsche et al. (2000) studied the CLA isomers distribution in beef samples and 
reported again the c9,t11 CLA as the predominant isomer (72%), followed by t7,c9 
isomer (7.0%).  
Despite its biological importance, t10,c12 isomer in ruminat products covers less than 
5% of the total CLA (Khanal and Olson, 2004). 
Dhiman et al. (2007) showed 17 natural CLA isomers found in milk, dairy products, 
beef, human milk, and human adipose tissue using silver ion-high performance liquid 
chromatography and gas chromatography-electron ionization mass spectrometry: 
t12,t14; t11,t13; t10,t12; t9,t11; t8,t10; t7,t9; t7,c9; t6,t8; c12,t14; t11,c13; c11,t13; 
c10,t12; c9,t11; c8,t10; c7,t9; c9,c11; and c11,c13.  
 
Synthesis 
CLA could be produced both by a ruminal biohydrogenation of C18:2 and C18:3 and 
by an endogenous synthesis in tissues from a rumen precursor.  
Ruminally, CLA is produced as an intermediate during the biohydrogenation of dietary 
C18:2 and C18:3 to stearic acid (C 18:0).  
Endogenously, CLA is synthesized from trans11 octadecenoic acid (C18:1, vaccenic 
acid (TVA)), by the ∆9- desaturase enzyme. A small portion of CLA produced in the 
rumen could escape further biohydrogenation to be absorbed by the digestive tract and 
CLA Biosynthesis 
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then used in tissues. (Griinari and Bauman, 1999).  
The endogenous synthesis of CLA from TVA has been proposed as the major pathway 
of CLA synthesis in lactating cows, accounting for an estimated 78% of the CLA in 
milk fat (Corl et al., 2001; Dawson et al., 1977) 
 
Rumen origin of CLA 
Reiser et al. (1951) and Shorland et al. (1955) firstly demonstrated the hydrogenation 
of dietary unsaturated fatty acids in rumen. 
Griinari and Bauman (1999) described the synthesis of CLA in two main steps. 
STEP 1: the Linoleic acid is isomerized to c9,t11 octadecadienoic acid. 
STEP 2: the cis-double bond is hydrogenated, and a trans-monoenoic acid is produced. 
trans11 vaccenic acid is accumulated in the rumen, becoming available for absorption 
in the small intestine, and partially transformed in C18:10 stearic acid.  
As a matter of fact CLA and TVA often escape a complete ruminal biohydrogenation, 
and are absorbed from intestine and incorporated into milk fat (Fig. 6) (Griinari and 
Bauman 1999; Jiang et al., 1996) 
 
 
 
 
 
 
 
 
 
 
Fig. 6 Predominant pathways of biohydrogenation in the rumen 
 
Similar to the biohydrogenation of C18:2, also C 18:3 fatty acids are are hydrogenated 
in the same way after isomerization of the cis-12 double bond, ending with the 
formation of  C18:0 in the case of complete biohydrogenation (Harfoot et al 1988; 
Griinari and Bauman, 1999). 
The relatively constant profiles of trans-octadecenoic acids found in ruminant meat 
and milk fat, where trans-11 octadecenoic acid is the predominant isomer, suggested a 
CLA Biosynthesis 
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relatively stable rumen bacteria population. Butyrivibrio fibrisolvens is the rumen 
bacteria mainly deputated to CLA synthesis, operating at the optimal condition of 
neutral pH (Kim et al., 2000). 
Studies with pure strains of ruminal bacteria have shown that most of the bacteria are 
capable of hydrogenating C18:2 to t-C18:1 and related isomers, but only few of them 
could reduce C 18:2 and C18:1completely to C18:0 (Fellner, et al., 1995). 
Interestingly, no single species of rumen bacteria catalyzes the complete 
biohydrogenation sequence (Harfoot et al., 1988; Kemp et al, 1984). 
Griinari et al. (1998) reported that a low fiber diets could affect the trans-octadecenoic 
acid profile of milk fat, probably due to an altered rumen profile: a predominance of 
trans10-octadecenoic acid among the trans-octadecenoic acid isomer of milk fat was in 
fact showed.  
Therefore a specific c9,t10 isomerase in rumen bacteria could be involved with the 
formation of a t10,c12 conjugated double bond as first intermediate (Fig.7) 
 
 
 
Fig.7. Alternative 
pathways proposed by 
Griinari and Bauman 
(1999) 
 
 
 
 
Thus rumen microflora can vary depending on cows’ diet. A diet providing PUFA, in 
particular LA, has been largely recognised as a factor enhancing CLA amount in milk 
and meat. Pasture feeding provides a high LA level, and, due to the LA toxicity to 
rumen microorganisms, biohydrogenation can be considered as a detoxification 
method. Anyway, Kim et al. (2000) reported that the ruminal biohydrogenation could 
be activated also by a discrete LA supplementation, avoiding negative effects on the 
rumen microflora, due to the slowly release of triglycerides with unsaturated fatty 
acids along ruminal digestion.  
CLA Biosynthesis 
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Tissue and milk origin  
As reported before, the CLA originating from the rumen was found inadequate to 
account for tissue and milk levels.  
Therefore, CLA must also be synthesized in tissues from a precursor of rumen origin 
(Fig. 8). Griinari and Bauman (1999) speculated that trans-11 octadecenoic acid could 
be the rumen-derived precursor of CLA in milk, due to the relatively constant ratio of 
trans-11 octadecenoic acid and CLA found in milk fat across a wide range of diets. 
They suggested a CLA endogenous production from trans-11 octadecenoic acid in 
tissues by ∆9-desaturase (a,bGriinari et al., 1997; Kay et al., 2004). 
The endogenous synthesis of CLA by ∆9-desaturase was largely investigated and the 
actual estimated endogenous synthesis of c9, t11 CLA in milk was 64, 78, or 80% of 
the total c9, t11 CLA, respectivel from the study of Griinari et al. (2000), Corl et al. 
(2001) and Lock et al. (2002). 
∆9-desaturase also showed different and specie-dependent distributions in tissues, and 
in lactating ruminants the mammary tissue showed the highest activity of this enzyme. 
(Kinsella et al., 1972). 
 
 
Fig. 8. CLA biosynthesis in rumen and tissues reported by Dhiman et al. (2007) 
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Human synthesis 
An endogenous CLA synthesis in human was suggested from the results of Salminen 
et al. (1998). The subjects in this study followed a diet basing on dairy products for 5 
weeks, then they consumed a diet high in stearic acid or high in vegetable fats 
(introducing 3g of trans-11/day) for a period of 5 weeks. The expected CLA intake 
based on the diet for the dairy period was 310 mg/d, for the stearic diet 90 mg/d and 
for the last diet 40 mg/d. The CLA concentrations analysed in serum lipids of the 
subjects after the different diets were found higher than calculated amount, after the 
introduction of hydrogenated lipids. Thus the authors concluded that a ∆9-desaturation 
of dietary trans-11 occurred after the consumption of vegetable fat.  
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V. CLA DIETARY SOURCES 
 
As reported above, the main CLA dietary sources are the dairy and meat products from 
ruminants. In particular the highest c9,t11 concentration was found in ewes’ milk 
(Banni et al., 1996; Jahreis et al., 1999) and cheese (Contarini et al., 2009; Cruz-
Hernandez et al., 2006; Prandini et al 2011) and in lamb meet (Chin et al., 1992; 
Fritshe and Steinhart, 1998; Dufey et al., 1999; Wachira et al., 2002; Badiani et al., 
2004; Knight et al., 2004).   
Dhiman et al. (2007) and Khanal and Olson (2004) reviewed CLA content in foods and 
showed the total CLA as % of fat as reported in the tables below. 
 
Tab 1. CLA in dairy products (Khanal and Olson, 2004) 
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Tab 2. CLA content in meats (Khanal and Olson, 2004) 
 
 
 
 
 
Table 3 and 4. CLA in dairy and meat products reported by Dhiman et al. (2007) 
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As expected, very small amounts of CLA have been found in milk, meat, or egg from 
non-ruminants (Bee, 2000; Chin et al., 1992, 1993). In tissue fat of chicken or swine 
fed normal concentrate diets, the CLA content was only around 0.1% of the total 
reported fat (Chin et al., 1993). However, feeding CLA as low as 1% of the diet may 
boost its content in the food products of non-ruminant origin by several folds (Raes et 
al., 2002; Ramsay et al., 2001; Thiel-Cooper et al., 2001).  
The CLA content in human milk was reported around 0.1% (Park et al., 1999).  
CLA concentration in foods was studied through different countries, and due to the 
different environment and feeding systems, some variations were found (Fogerty et al., 
1988; Shanta et al., 1997). Australian beef showed the highest values, with CLA as 1% 
of total fatty acids; CLA concentrations in german foods represented 0.65% of total fat; 
US beef hade the lowest values and CLA ranged from 0.3 to 0.5% of total fat. 
Moreover Wood (1983) found that US beef fat contained trans 10 as the major 
octadecenoic acid isomer rather than t11 as in fat from European beef (Wolff, 1995).  
In conclusion dairy products and meat could be CLA sources, but in each country a 
study must be performed, due to the variations that occurrs depending on animal diet, 
enviroment and dietary habits. 
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VI. FACTORS AFFECTING CLA 
 
The fatty acid compositions and consequently the CLA concentration of animal tissues 
can be strongly affected by numerous cross-linked factors: nutritional status, depot, 
breed, feeding and lactation stage and dietary factors (Duckett et al., 2002; Aharoni et 
al., 1995; Dihman et al., 1996; Kelly et al., 1998; White et al., 2001). Moreover an 
individual variation in milk CLA concentration was reported (Peterson et al., 2002; 
Kelsey et al., 2003). Therefore CLA content in ruminant products can be affected by 
all the factors above mentioned, and other factors related to the product manufacturing, 
as cheese processing parameters: aeration (Ha et al., 1989), temperature (Shanta et al., 
1992), milling pH, additives, and ripening (Lin et al., 1995) and the microbial cultures 
used.  
 
6.1 Diet 
As reported before, CLA in ruminant tissue and milk derived from the isomerization 
of LA and LNA during the biohydrogenation by rumen bacteria. The lipid availability 
and the microflora are key factors in the synthesis of CLA and they can be modulated 
by the source and the quantity of lipid substrates available (Chouinard et al., 2001; 
aKim et al., 2003) and by the feeding regimen.  
Griinari and Bauman (1999) divided the CLA dietary affecting factors in three groups: 
1) providing lipid substrate for CLA or trans-11 octadecenoic acid synthesis in the 
rumen; 2) affecting the rumen microflora involved in the biohydrogenation of fatty 
acids; 3) involving both lipid substrate and bacterial populations. 
Useful lipid substrates for rumen biohydrogenation could derive mainly from 
sunflower and linseed oil: sunflower oil is a source of C18:2 linoleic acid (LA), while 
linseed oil supplies C18:3 linolenic acid (LNA). 
Kelly et al. (1998) reported that sunflower oil resulted in highest CLA concentration in 
milk fat if compared with other oil supplementations (peanut oil, sunflower oil, and 
linseed oil, which are high in OLA, LA, and LNA, respectively). Similarly Dhiman et 
al. (a,b1999, 2000) studyied the effect of diet on CLA content of cows’ milk and found 
that some high-fat diets (mainly from soybean) could increase milk CLA content. 
However it must be underlined that a too high fat intake could depress milk fat 
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synthesis and in that case could affect the final CLA amount produced. 
The second group of dietary factors is instead related to a shift in the rumen microflora 
due to the effects of the ratio on the pH of the rumen. 
In particular a low-fiber diet was found to reduce the ruminal pH, increasing t10,12 in 
rumen digesta and in milk fat (Griinari and Bauman, 1999). Based on studies with 
lactating cows, Griinari et al. (1998) reported that this type of diet would lead to a 
change in the rumen environment, and finally would result in a decreased formation of 
t-11 octadecenoic acid in the rumen and, as a consequence, in a decreased CLA 
concentration in tissues. 
Thus the lower relative proportion of the c9,t11 isomer related to a a change in the 
ruminal biohydrogenation could be induced by traditional high concentrate/low fiber 
finishing diets, and an altered profile of CLA isomers characterized by an elevated 
level of t10,c12 isomer could be found in the milk fat of lactating dairy cows fed a low 
fiber diet. 
Moreover it was reported that also feeding seeds from linseed or soybean in a low 
forage diet regimen (30:70 forage to concentrate ratio) would not increase milk fat 
CLA (Chilliard et al., 2003). It was hypothesized that low forage in the diet could  
reduce the rumen pH below 6.0, which has negative effects on both CLA and TVA 
concentrations in the rumen (Troegeler-Meynadir et al., 2003; Martin and Jenkins, 
2002).  
The effect of dietary fiber on CLA content in meat of growing cattle was demonstrated 
in a study in which pasture feeding increased CLA content of body fat compared with 
that observed with traditional grain diets (Shanta et al., 1997).  
Moreover the CLA enhancing role of diet, in relation to a balance of the rumen 
environment, was demonstrated also by Fritshe and Fritshe (1998). The authors 
analyzed subcutaneous and intermuscolar fat samples from cattles after a corn-silage 
feeding providing a sufficient amount of fiber to maintain normal rumen fermentation, 
and found that c9,t11 isomer covered >90% of total CLA. 
Regarding the group 3, a lot of studies confirmed the role of pasture feeding in 
enhancing the milk CLA concentrations in dairy cows with an increase in CLA related 
to increasing proportions of pasture in the diet (Jahries et al., 1997; Stanton et al., 
1997; Kelly et al., 1998; aDhiman et al., 1999; Collomb et al., 2002; Collomb et al., 
2004; Leiber et al., 2005; Parodi et al., 1999; Rego et al., 2005). For example Couvreur 
et al. (2006) found a linear increase in CLA, MUFA and PUFA in milk at the expense 
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of SFA percentage replacing corn silage with increasing proportions of fresh cut grass 
in the cow diet.  
The enhancing effect on CLA amount of pasture feeding is mainly due to the 
supplementation of PUFA, precursors of CLA. Linoleic acid is basic for the rumen 
synthesis of TVA and its subsequent desaturation to c9,t11 CLA in the mammary 
gland (Bauman et al., 2003). 
In contrast the ensilaging includes conservation processes thet may reduce where 
PUFA in herbage: Elgersma et al. (2003) reported a decrease in the proportion of LNA 
in ensiled material in comparison to fresh grass.  
Moreover the hay fed during summer could have higher content of CLA precursors 
than hay fed in winter-early spring, due to the lower oxidation process related to the 
duration of the storage (Dewhurst et al., 2006).  
As a matter of fact the CLA enhancing role of fresh grass is more evident during 
summer: Prandini et al. (2009) showed that Grana Padano produced in lowland- hill in 
Italy in summer months, after a greater quantity of fresh forage, contained higher 
amount of CLA, oleic acid and MUFA and lower levels of SFA if compared to spring 
cheese. 
Ledoux et al. (2005) found important differences in CLA content between summer and 
winter butter (0.80 and 0.45 g CLA·100 g-1 butter, respectively). The same authors 
showed that milk from mountainous areas had a higher CLA content than milk from 
lower regions. In their recent review on the variation of CLA in unprocessed milk fat, 
Collomb et al. (2006) reported values ranging from 0.2 to 5.37 g·100 g–1 fat. However 
the highest reported value was from a study of Shingfield et al. (2006) obtained by a 
diet supplemented with fish oil and sunflower oil. 
 
 
6.2 Lactating season 
The lactation season has been thought to have a strong impact on cheese quality. 
Since 1953, McDowell and McDowell showed a seasonal variation of CLA, found 
substantially higher in spring and summer (when cows were pastured) than in fall and 
winter (when cows were house-fed), that could be compared with the trend of oleic 
acid content in butter fat. Then Parodi et al (1999) reported from literature the same 
trend of CLA amount in milk during seasons and Rego et al. (2008) again noted that 
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summer milk fat contained more conjugated dienoic fatty acids than winter milk fat. 
Moreover differences of fatty acid composition and CLA concentration in cheese were 
seen in the work of Prandini et al. (2009) between spring and summer. In this work 
summer Grana Padano from mountains (M-GP) had a better fatty acid composition 
than spring M-GP, with higher levels of beneficial fatty acids for human health (CLA, 
TVA, oleic acid, MUFA and PUFA) and lower levels of detrimental fatty acids (SFA). 
Thus, from all of these results, the effect of the production season of the milk used in 
cheese manufacturing and of the relations between production season and area could 
be clearly underlined.  
 
 
6.3 Breed  
 
Kelsey et al. (2003) showed that Holstein could provide a greater CLA content of milk 
compared to Brown Swiss in similar feeding condition; however, despite the 
significance of their results, the differences were inconsequential if compared with the 
effects of dietary manipulation or the variation among individuals. Thus they 
concluded that breed effect could account for only 0.1% of the total variation in the 
CLA concentration in milk fat. 
Thus more studies on the genetic mechanism involved in CLA pathways must be 
performed to understand the breed effect. In this work a short trial was conducted to 
underline differences in CLA synthesis by two breeds drammatically different in the 
lipid metabolism (See Manuscript 5). 
 
6.4 Microbial starter 
A lot of studies were carried out regarding the influence of microorganisms on CLA 
content in dairy products and a review on these studies was published by Sieber et al. 
(2004). Strains of lactobacilli, bifidobacteria and propionibacteria were found to be 
able to convert linoleic acid efficiently into CLA in milk. However, the same effects 
were not showed in the investigations on yoghurt and cheese. 
Bifidobacteria, propionibacteria, Lb. plantarum, Lb. rhamnosus and Lb. acidophilus 
mainly showed a high linoleic acid conversion. 
From literature, free linoleic acid has been recognized as a needed substrate, even if a 
careful check must be done regarding its optimal amount, because a too high amount 
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of linoleic acid could reduce the conversion rate into CLA (Alonso et al, 2003; Ogawa 
et al, 2005; Oh et al., 2003).  
 
Bifidobacteria 
Coakley et al. (2003) reported the production of c9,t11 CLA isomer by some 
propionibacteria strains from free linoleic acid. Some B. breve and B. dentium strains 
were reported as the most efficient CLA producers. For example B. breve NCFB 2258 
converted 65% of the linoleic acid into CLA.  
The CLA production by bifidobacteria was suggested by the authors as a possible 
mechanism for health- enhancing properties, in according to Oh et al. (2003), who 
screened about 300 colonies of bifidobacteria strains isolated from breast-fed infants 
regarding their ability in producing CLA. Reasonable amounts of CLA were produced 
by different colonies; among them B. breve and B. pseudocatenulatum were the most 
active: the total CLA conversion from 0.01% linoleic acid was 78% for B. breve and 
69% for B. pseudocatenulatum. 
 
Propionibacteria 
Jiang et al. (1998), Rainio et al. (2002), Ross et al. (2000) and Sieber 2004 reported the 
efficiency of propionibacteria in the conversion of linoleic acid into CLA with rates of 
up to 87%. In the work of Jiang et al. (1998) strains of Propionibacterium 
freudenreichii ssp. freudenreichii and P. freudenreichii ssp. shermanii converted free 
linoleic acid into CLA (mainly c9,t11) in skimmed milk. Also Xu et al. (2004) found a 
CLA increase due to some strains of Propionibacterium freudenreichii ssp. shermanii 
and P. freudenreichii ssp. freudenreichii.  
Anyway Gnädig et al. (2004), investigating the effect of some strains of 
Propionibacterium freudenreichii in comparison with cheese manufactured without 
propionibacteria, did not reported any alteration in CLA content or CLA isomer 
composition. 
 
Lactobacilli 
A lot of study on the Lactobacilli effect on CLA concentration were conducted (Jiang 
et al. (1998), Lin et al. (1999), Pariza and Yang (1999, 2000), Ogawa et al. (2001), 
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Kim and Liu (2002), Kishino et al. (2002), Coakley et al. (2003) and Alonso et al 
(2003)). The results were contrastant: Kim and Liu (2002) found an increasing CLA 
content in whole milk due to the lactobacilli fermentation, while Coackley et al. (2003) 
did not reported any detectable CLA production by lactobacilli, lactococci and 
pediococci. 
 
6.5 Cheese processing 
 
Contrasting results were found regarding the existence of cheese processing effects on 
CLA concentration. 
Steinhart (1996) reported that processing, such as heating, could change the CLA 
isomer distribution in dairy products while the total CLA content remained unchanged 
after conventional processing. 
Ha et al. (1989) and Garcia-Lopez et al. (1994) reported increased levels of CLA in 
processed cheeses as compared with natural cheeses.  
In contrast Bisig et al. (2007) reported that manufacturing processes have no effect on 
CLA, while Kim et al. (2009) reported that CLA content could be affected by 
fermentation, temperature, pH, additives and ripening. Ha et al. (1989) and Shanta et 
al. (1992) reported the importance of aeration, heating temperature and pH, because 
LA isomerization is a pH-dependent reaction. Finally Kim and Liu (2002) reported that 
lactic acid bacteria increased the CLA content during cheese fermentation and an 
increase in CLA content by microbial cultures during cheese ripening was found also 
in the works of Jiang et al. (1998) and Sieber et al. (2004). 
Kim et al. (2009) reported that both in pasture and indoor feeding the extension of 
ripening period increased CLA content in cheese: CLA in processed cheese was 
enhanced by ripening for 4 months compared with that in raw milk samples. 
However, CLA level in 7 month-aged cheese did not show a significant difference 
between pasture and indoor feeding. This suggested that the CLA level in milk from 
indoor feeding could be strogly affected than the one from pasture feeding by the long-
term ripening process. Also Lin et al. (1999) and Gürsoy et al. (2003) detected the 
highest CLA content in cheeses with a long aging time, respectively analyzing 
Cheddar and Turkish cheeses. In addition Ha et al. (1989) and Prandini et al. (2001) 
reported higher CLA contents in cheese than in the raw milk.   
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Anyway Werner et al. (1992), Jiang et al. (1997), Gnädig et al. (2004), Nudda et al. 
(2005) and Ryhänen et al. (2005) did not observed any process effect on the CLA 
content in Edam cheese, Swedish Swiss- type cheese, French Emmental and other hard 
cheeses, and Pecorino Romano cheese and Ricotta cheese. 
The heating temperature during cheese processing could also affect CLA concentration 
in processed cheese: Cheddar cheese heated to 80-90 C had a higher CLA content if 
compared with cheese heated to 70 C (Shanta et al, 1992).  
Anyway, the heating was proposed as the only process involved in CLA increase 
during cheese manufacturing by Fernandez-Garcia et al. (1994) that suggested that 
high temperature enhanced the formation of LA radicals resulting in a conjugated 
system in the fatty acid backbone.  
These findings were discordant with the studies of van Nieuwenhove et al. (2004) and 
Luna et al. (2004) who did not found any increase in CLA levels in imlk fat after 
heating at a high temperature, and Gnädig et al. (2004), studiyng mildly heating 
processes on milk (68 °C/20 s) and several cooking/moulding temperatures of 52 
°C/50 °C or 48 °C/48 °C or 50 °C/ 50°C, did not reported any effect on CLA content in 
French Emmental cheese. 
In addition Campbell et al. (2003) and Precht et al. (1999) observed losses of CLA 
through high- temperature-short-time pasteurisation or more severe heat treatment up 
to 200 °C. 
As previously reported, also fermentation could be another process involved in 
enhancing the CLA concentration in dairy product. The activity of some lactic acid 
bacteria increased CLA content in the study of Kim an Liu (2002). 
In addition, the role of pH must be reminded. As reported in paragraph 6.1,  LA 
isomerization is a pH dependent enzymatic reaction, thus an acidic environment 
induced by high concentrate could be antagonistic to CLA production. Thus another 
variable that must be monitored during the cheese manufacturing is pH. 
 
 
 
 
 
CLA Healthy Properties 
 28
 
VII. CLA HEALTHY PROPERTIES 
 
CLA isomers were found to exert healthy effects with anticarcinogetic (Ha et al., 1990; 
Ha et al., 1987; Ip et al., 1991; Liew et al., 1995; Belury 2002; Belury et al., 1996; bIp 
et al, 1999), anti-atherosclerotic (Lee et al., 1994; Nicolosi et al., 1997; a,bKritchevsky 
et al., 2000; Koba et al., 2002), anti-insulin resistance (Ryder et al., 2001; Houseknecht 
et al., 1998), anti-inflammatory (Yang et al., 2003; Yu et al., 2002; Iwakiri et al., 2002; 
Miller et al., 1994; Cook et al., 1993) and anti-adipogenic properties (Park et al., 1997; 
Park et al., 1999; Pariza et al., 2001; Luna et al., 2004; Luna et al., 2005; Lynch et al., 
2005).  
Some studies reported CLA positive physiological effects using mixtures mostly of 
c9,t11 and t10,c12 CLA in approximately equal amounts and very low amounts of the 
others isomers, while other studies showed separate actions of c9,t11 and t10,c12 
isomers. Thus it could be suggested that some effect are isomer-dependent and others 
others are induced and/or enhanced by the synergic action of the two isomers.  
 
 
7.1  Anti-carcinogenetic effect 
 
CLA has been described as an anti-carcinogenic agent since the last two decades, due 
to its role in inhibiting the chemically-induced carcinogenesis in several rodent models 
(Ha et al., 1990; Ip et al., 1991; Liew et al., 1995). Based on diet and cancer risk 
studies, and on CLA amount required for an anti-carcinogenic response extrapolated 
from rats to humans, Ip et al. (1994) proposed a needed daily CLA intake ranging from 
55 mg above basal CLA intake to 3.0 to 3.5 g/d to provide anti-carcinogenic response 
in humans.  
A good skill in the prevention of carcinogenesis was showed by CLA in different 
tissues (Dilzer et al., 2012) and in a large number of animal studies (Lee et al., 2005; 
Bhattacharya et al., 2006; Kelley et al., 2007).  
However the efficacy was reported mainly in in vitro and animal studies, while only 
few human studies were conducted and controversial results were reported.  
CLA could be involved in cancer prevention modulating eicosanoids production, 
interfering in cell signaling pathways, inhibiting DNA synthesis, promoting apoptosis, 
and modulating angiogenesis (Masso-Welch et al., 2004; Lee et al., 2005; Lee et al., 
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2006; Wang et al., 2005; Beppu et al., 2006; Bhattacharya et al., 2006; Kelley et al., 
2007; Flowers and Thompson, 2009; Hsu et al., 2010). 
The first human study was conducted by Knekt et al. (1996). 
In this study the dairy intake in 4697 cancer free women was analyzed; then food 
consumption data from these subjects were collected for the following 25 years. The 
results showed a significant inverse gradient between milk consumption and breast 
cancer incidence within participants. This suggested a protective effect linked to milk 
consumption and CLA was suggested as one of the potential active components.  
Moreover Aro et al. (2000) conducted an analysis on dietary habits in a cohort of 
Finnish patients with breast cancer, and found that a diet consisting of CLA-rich foods, 
especially cheese, may have anticarcinogenic effects with regard to breast cancer in 
post- menopausal women. However, the study design could not allow the assessing of 
independent effects of CLA. In addition, in other works, no effect or only a weak 
positive correlation was showed between CLA intake and breast cancer incidence 
(Voorrips et al., 2002; McCann et al., 2004).  
Dietary CLA intake and CLA levels in breast adipose tissue at the time of diagnosis or 
subsequent the development of metastasis did not show any significant association 
between CLA levels and prognostic factors or risk of metastasis or death (Chajes et al., 
2002-2003). Similarly, no correlations between serum CLA levels and breast cancer 
incidence were found by Rissanen et al. (2003). 
Larsson et al. (2005), reported instead an inverse correlation between CLA and 
colorectal cancer incidence in women.  
Thus the lack in sufficient positive results do not allow to demonstrate the CLA 
efficacy against cancer in humans. More trials are necessary in order to determine the 
mechanisms of action and the specific effects of CLA isomers associated with cancer. 
 
Gastrointestinal and colon cancer 
 
Information on the beneficial effects of CLA on gastrointestinal and colon cancer has 
been derived mainly from animal and in vitro studies. In the first decade of 2000 a lot 
of studies were conducted about this issue and quite all of them agreed in the 
acknowledgment of a beneficial role of CLA isomers in preventing this type of cancer 
(Bhattacharya et al., 2006; Wahle et al., 2004). 
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It was showed by aCho et al. (2003) that CLA could inhibit cell proliferation and 
induce apoptosis of HT-29 cells. Another study suggested that t10,c12 (not c9,t11) 
inhibited Caco2 colon cancer cells through decreased IGF-II secretion (aKim et al., 
2002). As a matter of fact the same group reported that CLA-associated benefits could 
be in part associated with its skills in decreasing the insulin-like growth factor (IGF) II 
synthesis and in down-regulating the extracellular signal-regulated kinase-1/2 pathway 
and IGF-I receptor signaling (bKim et al., 2003). In the same year bCho et al. (2003) 
obtained similar results in HT-29 cancer cells where t10,c12 decreased viable cell 
numbers dose dependently, concluding again that the inhibition of H-29 cells by 
t10,c12 isomer was mediated through the inhibition of IGF-II secretion. 
In 2006 Lee et al. showed that t10,c12 isomer repressed cell proliferation and induced 
apoptosis. 
Moreover the usual contemporary presence of the two isomers must be considered: 
individual isomers were found to have stronger inhibitory effects if compared to a 
mixture of CLA isomers in a study evaluating the effects of 98% pure c9t,11 and 
t10,c12 CLA isomers in benzo[a]pyrene-induced forestomach neoplasia (Chen et al., 
2003). Anyway a recent work of Zhong et al. (2012) reported that the c9,t11-CLA and 
t9,t11-CLA mixture (1:1 v/v) could inhibit the growth of Caco-2 cells in a dose and 
time dependent manner, and can induce the apoptosis of Caco- 2 cells.  
Some studies investigated the dose needed to exert these beneficial effects: Park H,S. 
et al. (2001) showed that 1% CLA of the diet for 30 weeks reduced 1,2- 
dimethylhydrazine (DMH)-induced tumor incidence in the colon of SD rats; Cheng et 
al. (2003) examined the dose-dependent inhibitory effects of CLA on mammary and 
colon carcinogenesis induced by treatment with 7,12-dimethylbenzanthracene and 
DMH in SD rats and found again the dietary level of 1% CLA as the optimal dose for 
suppression of carcinogenesis in both target organs.  
Anyway controversial data were found in a study on Min mouse model of intestinal 
carcinogenesis where animals were fed purified isomers at 1% of the diet: the t10,c12 
isomer was found promoting carcinogenesis (Rajakangas Jet al., 2003). 
In 2005 a study in BALB/c nu/nu mice, inoculated with MKN28 (human gastric cancer 
cells) and Colo320 (human colon cancer cells) in their peritoneal cavity, showed 
decreased metastatic foci in peritoneal cavity with CLA intake, indicating that CLA 
inhibited metastasis of human gastric and colon cancer cells (Kuniyasu et al., 2005).  
Anyway, as reported before, there is unfortunately a lack of human studies.  
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Larsson et al. (2005) reported a decrease of 13% in the risk of colorectal cancer and of 
34% of distal colon cancer for a daily increment of two servings of high-fat dairy 
foods. However the authors concluded that the observed protective effect of high-fat 
dairy foods could only be partly attributed to CLA intake.  
Thus in vivo and in vitro studies suggested that both CLA isomers in equal proportion 
either the t10,c12 isomer alone could prevent gastro-intestinal and colon cancer. 
However, more human studies are needed to propose CLA isomers as an active agent 
in preventing cancerogenesis. 
 
Breast cancer 
Initial in vitro study in MCF-7 breast cancer cells showed that CLA was growth-
inhibitory in culture, but was more cytotoxic to MCF-7 cells (Shultz et al., 1992).  
Interestingly, CLA inhibited growth and thymidine incorporation of MCF-7 cells, 
whereas LA was found to be stimulatory (Cunningham et al., 1997). The effect of CLA 
could be mediated through lipoxygenase inhibition because the CLA addition with a 
lipoxygenase inhibitor resulted in synergistic growth suppression. 
Moreover Miller et al. (2001) reported that the growth- suppressing effects of CLA 
isomers in MCF-7 cells might be related to changes in arachidonic acid distribution 
and to an altered PG profile.  
Different mechanisms were hypotesized for c9,t11 and t10,c12 isomers in the 
inhibition of MCF-7 cells proliferation.  
Chujo et al (2003) showed that t10,c12 inhibited cell proliferation when induced by 
insulin and estrogen. None of these factors instead affected c9,t11-mediated inhibition 
of cell proliferation.  
Moreover in 2004 CLA isomers were showed to down-regulate the estrogen receptor 
expression at mRNA and protein levels, and to decrease binding of nuclear protein to a 
normal estrogen response element. Thus in this study the antitumoral activity could be 
explained by antiestrogenic properties (Tanmahasamut et al., 2004). 
Wang et al. (2005) found again that both the isomers seemed to be active: MCF-7 
cancer cells were co-cultured with human breast stromal cells in the presence of c9,t11 
and t10,c12 CLA isomers and both decreased mRNA vascular endothelial growth 
factor (VEGF) expression and protein levels in the cancer cells (Wang et al., 2005). 
However, t10,c12 CLA appeared to be the more active isomer of the two. 
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Also in animal studies CLA was found to be an effective agent in inhibiting the 
development of mammary tumors. In one of the first studies, Ip et al (1991) fed rats 
with diet supplemented with 0.5%, 1%, or 1.5% CLA from 2 weeks before the 
carcinogen administration and continued until the end of the experiment. The 
mammary adenocarcinomas decreased by as much as 60%; the final tumor incidence 
and cumulative tumor weight were lowered in rats fed with CLA diets.  
Another study by Ip et al. (1996) reported that the protective effect of CLA was not 
influenced by the level or type of fat of the diet. More recent studies by Ip et al. (Ie. Ip 
et al., 2003) indicated that CLA may prevent breast cancer also through its 
antiangiogenic activity.  
Some studies coupled the CLA action with known anticarcinogenic agents. A work of 
Tao et al. (2012) showed an enhanced anticancer activity of the Gemcitabine if coupled 
with CLA. 
Only few clinical studies were conducted to study the effects of CLA on breast cancer 
and no correlations were found. 
Thus, although results from in vitro and animal studies reported a cancer inhibition 
related to a CLA introduction, no demonstrations nowadays exsist on CLA role against 
human breast cancer. 
 
 
Prostate cancer 
In vitro studies suggested that both the CLA isomers c9,t11 and t10,c12 could have 
beneficial effects against prostate cancer. 
Palombo et al. (2002) and Ochoa et al. (2004) analyzed the effects of CLA isomers on 
PC-3 prostate carcinoma cell line in vitro. The isomers differed in their 
antiproliferative activity and t10,c12 was found more beneficial comparing with 
c9,t11. The second study concluded that the effects of t10,c12 were mediated through 
modulation of apoptosis and cell cycle control, while c9,t11 mediated its effects 
through alternation in AA metabolism.  
A study conducted on LNCaP prostate cells reported that the antiproliferative activity 
of CLA isomers and their role in affecting the protein kinase C isoforms could partly 
explain their antitumorogenic activity (Song et al. 2004). 
The lack in in vivo and human experiments could not allow any conclusion regarding 
the beneficial effects of CLA on prostate cancer. 
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Angiogenesis 
Masso-Welch et al. (2002) and Ip et al. (2003) showed a CLA-dependent inhibition of 
angiogenesis in vivo in implanted rat breast tumors. CD2/F(1) mice were given 
angiogenic challenge after treating them with 1% and 2% CLA for 6 weeks. 
CLA-fed mice had lower serum and mammary gland levels of VEGF. In these studies, 
c9t11 and t10c12 CLA isomers inhibited angiogenesis in vitro dose dependently. Thus 
it was suggested that the anti-angiogenic effects of CLA could be mediated, in part, 
through the VEGF and its Flk-1 receptor inhibition.  
Moreover another study by Masso-Welch et al. (2004) showed that both c9,t11 and 
t10,c12 CLA at 0.5% and 1.0% of the diet could inhibit angiogenesis in vivo and 
decrease VEGF in CD2/F(1) mice. However the proangiogenic hormone leptin, was 
decreased only with t10,c12 CLA diet.  
Another factor involved in angiogenesis is the basic fibroblast growth factor (bFGF). 
Moon et al. (2003) showed a CLA inhibition of bFGF-induced angiogenesis in vivo 
and decreased bFGF-induced endothelial cell proliferation and DNA synthesis in vitro.  
Thus the results suggested a positive effect of CLA isomers against angiogenesis, and 
that the anti-angiogenic activity could be the CLA mechanism to inhibit cancers. 
However no published reports evaluating the effects of CLA on angiogenesis in 
humans are currently available. 
 
7.2   Anti-atherosclerotic effects 
In the work of Lee et al. (1994) a diet containing a CLA isomer mixture (0.5 g/day) for 
22 weeks determined a lower atherosclerosis if compared with an atherogenic diet and 
a control diet. Moreover 1% of CLA reduced an induced atherosclerosis in rabbits of 
33% (Kritchevsky et al., 2000). Follow-up studies reported the efficacy of mixed CLA 
isomers, and a similar effect also exerted by the major CLA isomers c9,t11 and t10,c12 
(Kritchevsky et al., 2004; Kritchevsky et al., 2002).  
Studies on hamsters suggested that CLA or the individual isomers could be more 
effective against atherosclerosis when diet is high in saturated fat (Wilson et al., 2000; 
Mitchell et al., 2005; Valeille et al., 2005; Nicolosi et al., 1997). 
However the effects of CLA isomers on atherogenic risk factors showed considerable 
variations, despite the evidence on atherosclerotic lesions (Lee et al., 1994; Nicolosi et 
al, 1997; Kritchevsky et al., 2000; Munday et al., 1999; de Deckere et al., 1999; 
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Valeille et al., 2004; Stangl et al., 2000a,b). Thus the mechanisms involved in the anti-
atherosclerotic effects of CLA isomers have not yet been adequately addressed in both 
in vitro and in vivo studies.  
Moreover atherosclerosis can be strictly related to obesity, metabolism disorders and 
hypertension. 
Thus a positive effect of CLA on these factors could be suggested as an indirect CLA 
mechanisms affecting atherosclerosis. 
CLA coul exert a role on the lipid metabolism through the action on PPARs, SREBPs 
and SCD. Peroxisome proliferator-activated receptors are ligand-activated nuclear 
receptors regulating the expression of genes that control lipid and glucose homeostasis, 
thus modulating the major metabolic disorders predisposing to atherosclerosis (Pineda 
Torra et al., 1999). Moreover, PPARs exert additional anti-inflammatory and lipid-
modulating effects in the arterial wall, therefore being interesting molecular targets for 
the treatment of atherosclerosis (Marx et al., 2001). 
Studies with pure isomers suggested that c9,t11 is more effective than t10,c12 in 
modulating key factors of lipid metabolism. Although both c9,t11 and t10,c12 isomers 
are ligands for PPARα, results showed that c9,t11 isomer is the most effective 
activator (Moya et al., 1999). 
c9,t11 isomer was also shown to down-regulate mRNA expression of SREBP-1c, 
whereas the t10,c12 isomer did not showed any effect (Roche et al., 2002) 
The complex relation between CLA and lipid metabolism will be discussed in the 
paragraph below. 
Hypertension is another factor that could be associated with an increased risk of 
cardiovascular diseases. 
t10,c12 CLA isomer or a mixture of the two isomers (50:50) were found to decrease 
the blood pression with a positive effect on hypertension by a,bNagao et al. (2003) and 
Innoue et al. (2004). 
Despite the CLA effect found on risk factors for cardiovascular health in animal 
studies, the results in the few human studies were discordant (Benito et al., 2001; 
Smedman et al., 2001; Petridou et al., 2003; Mougios et al., 2001; Noone et al., 2002; 
Tricon et al., 2004; Riserus 2002-2004; Moloney et al., 2004; Naumann et al., 2005; 
Gaullier et al., 2005). 
Thus the beneficial effects of CLA on atherosclerosis need to be highlighted in more 
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clinical studies, and the understanding of the underlying mechanisms is required. 
Moreover the role of both the isomers should be identified. 
 
7.3   Anti-adipogenic effects  
As reported above, obesity is a pathologic condition related to risk factors such as 
cardiovascular disease, diabetes and cancer (Dilzer et al., 2012; Aminot-Gilchrist and 
Anderson, 2004). Therefore the CLA role in the control of body fat mass in animals 
and humans has been widely considered of interest (Park et al., 1997; Park, 2009). 
CLA was suggested to enhance the lipolysis or decrease the fatty acid uptake in 
adipocytes by Park et al (1997) and to increase the energy expenditure and fat 
oxidation (West et al., 1998, 2000; Terpstra et al., 2002; Ohnuki et al., 2001), decrease 
the adipocyte size (Tsuboyama-Kasaoka et al., 2000; Azain et al., 2000; Poulos et al., 
2001) and the energy intake (West et al., 1998). 
Moreover a basic role of CLA could be exerted in the inhibition of enzymes involved 
in fatty acid metabolism and lipogenesis (Park et al., 1999; Tasuboyama-Kasaoka et 
al., 2000; a,bPark and Pariza, 2001; bPark et al., 2000; Bretillon et al.,1999; Takahashi 
et al., 2002)  
These hypotheses were supported by other studies that showed that CLA decreased fat 
mass and enhanced lean mass (Houseknecht et al., 1998; DeLany et al., 1999; West et 
al., 1998; Tsuboyama-Kasaoka et al., 2000;West et al., 2000; Ostrowska et al., 1999; 
Azain et al., 2000; Dugan et al., 1999; Atkinson et al., 1999; Halvorsen et al., 2000). 
t10,c12 is the CLA isomer most involved in fat mass reduction, as reported from 
animal and in vitro studies (Park et al., 1999; Park and Pariza, 2007; Ryder et al., 2001; 
Choi et al., 2000; Navarro et al., 2003; a,bRiserus et al., 2002; Belury et al., 2003; 
Malpuech-Brugere et al., 2004; Herrmann et al., 2009). In vitro and in vivo studies 
showed the t10,c12 effect in fat reduction through a decreased adipocyte size (Evans et 
al., 2000), an increased fat oxidation (Martin et al., 2000) and an inhibition of enzymes 
involved in lipogenesis (Choi et al., 2000; a,bPark and Pariza, 2001). Moreover aNagao 
et al. (2003) recently showed that t10,c12 isomer increased oxygen consumption and 
energy expenditure, more than the c9,t11 isomer. 
In the last study the effect of 6 weeks of supplementation of 0.5% LA, c9,t11 CLA or 
t10,c12 CLA in atherogenic diet-fed hamsters was investigated and a significant 
decrease of the fat mass in t10,c12-fed hamsters was obtained.  
Also other studies reported similar results (Simon et al., 2006 and Obsen et al., 2012) 
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However it was also suggested that CLA was more effective in lowering fat mass when 
the diet was deficient in essential fatty acids (Kloss et al., 2005; Hargrave et al., 2004). 
As for the other CLA physiological effects, only few studies examined the effects of 
CLA or its isomers on body fat mass in humans. Moreover, as in the other cases, the 
results were not as dramatic as in animal trials and were discordant.  
Zambell et al. (2000) and Petridou et al (2003) did not found any effect of CLA 
somministration (respectively 3g for 64 days and 2.1g for 45 days). However, two 
studies in healthy exercising humans (CLA, 1.8 g/day) and in overweight and obese 
subjects (from 1.7 to 6.8 g/day for 12 weeks) showed that CLA could decrease fat 
mass without significantly affecting body weight (Thom et al., 2001; Blankson et al., 
2000). Thus exercise was suggested as an enhancer of the fat-lowering effects of CLA. 
Positive effects of CLA in human trials were also reported by Riserus et al. (2001) and 
Mougios et al. (2001). Moreover two long-term trials (12 month) conducted on healthy 
overweight humans by Gaullier et al. (2004, 2005) showed a significant decrease in 
body fat mass and the decrease in fat mass obtained in the second trial was maintained 
over a period of 24 month, thus suggesting that CLA might help in the maintenance of 
the reduction in fat mass. In addition Kamphuis et al. (2003) reported that CLA 
promoted lean body mass weight regain after a weight loss regiment and Watras et al. 
(2007) showed that a CLA supplementation for 6 months prevented the weight 
increase during the holiday season; also Whigham et al. (2007) and Park (2009) results 
suggested that a CLA long-term supplementation could affect the body fat mass. 
Anyway the human studies where CLA was supplemented through the intake of dairy 
foods did not showed the same healthy effects (Malpuech-Brugere et al., 2004; 
Desroches et al., 2005). 
The review of Dilzer et al. (2012) underlined a possible effect of CLA on satiety in 
relation to the work of Gaullier et al. (2005). 
As a matter of fact Kamphuis et al. (2003), Blankson et al. (2000) and Whigham et al. 
(2004) reported that CLA could affect hunger and satiety and reduce appetite, and 
Malpuech-Brugere et al. (2004) reported a reduction in average caloric intake by CLA 
supplemented subjects. However, the works of Lambert et al. (2007), Atkinson (1999); 
Gaullier et al. (2007); Iwata et al. (2007); Watras et al. (2007); Cornish et al. (2009); 
Norris et al. (2009) and Wanders et al., 2010 did not show any effect of CLA on these 
factors.  
The mechanisms undergoing the CLA effect on body fat mass involved genetic 
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pathways. A study of Kang et al (2004) suggested that the CLA effects could be 
dependent by FAS and uncoupling protein (UCP) gene expression, and not by SCD, in 
according with Choi et al. (2004) and Ryder et al. (2001).  
However a study of Obsen et al. (2012), reporting the predominance of t10,c12 in lipid 
lowering, suggested that t10,12 CLA could decrease SCD-1 activity, thereby reducing 
the MUFA needed for neutral and compound lipid synthesis.  
As a matter of fact SCD knockout mice have lower synthesis of TG and cholesterol 
esters (Miyazaki et al., 2000), and SCD1-deficient animals also produce low levels of 
VLDL, suggesting that the rate of VLDL production might itself be influenced by 
SCD1 activity (Miyazaki et al., 2000, 2001). 
Thus, inhibition of SCD1 activity could be one of the mechanisms involved in the 
lipid-lowering effect of CLA. 
Also Choi et al. (2000) reported a repression of SCD gene expression in adipocytes by 
t10,c12. Moreover this effect was mainly exerted by t10,c12 than c9,t11 isomer (Choi 
et al., 2001). 
Obsen et al. (2012) also found that t10,c12 CLA could affect SREBP-1c pathway in 
bovine adipocyte, could decrease PPAR activity, thereby reducing the expression of 
adipogenic and lipogenic proteins needed for lipid biosynthesisand could finally 
increase inflammatory lipid metabolites or signals that antagonize glucose and FA 
uptake and subsequent metabolism ( i.e., GLUT-4). 
Other studies suggested instead that c9,t11 isomer positively influences lipid 
metabolism by reduced synthesis and cleavage of hepatic SREBP-1.  
The absence of dramatic evidence of CLA effect in human trials could be due to the 
CLA dosage that is lower in these studies than in animal studies.  For example, in the 
study of Malpuech-Brugere et al. (2004) on mice, CLA was supplemented 0.5 w/w% 
(the same as 56 g CLA/day/70 kg), while in human studies the CLA supplementation 
ranged from 0.7 to 6.8 g/day as reported above.  
Moreover, the human studies were mainly conducted with adults, while in animal trials 
the young subjects gave the most interesting results. Dilzer et al. (2012) also proposed 
the dietary regime as a factor affecting the CLA effects on fat mass: a test during 
dietary restriction did not show any reduction of body fat in mice (aPark et al., 2007) 
and humans (Whigham et al., 2004; Larsen et al., 2006; Diaz et al., 2008; Park, 2009), 
while CLA effects could be found during a weight gain period (Atkinson, 1999; 
Kamphuis et al., 2003a; 2003b; Whigham et al., 2004; Larsen et al., 2006; Watras et 
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al., 2007). 
In addition, the same author reported other factors as subject weight status (normal, 
overweight, or obese), age, physical activity, physical condition, dietary interactions, 
or other medications or supplements that could be involved in the modulation of CLA 
effects in humans. 
 
7.4 Effect against Insulin resistance 
 
The animal and human studies regarding the CLA effects on glucose metabolism 
showed inconsistent results: most of them reported increased insulin resistance (IR) by 
CLA in normal animals but reduced insulin resistance in obese models (O’Hagan and 
Menzel, 2003; Wargent et al., 2005; Park and Pariza, 2009; Park, 2009), while effects 
of CLA on glucose metabolism in humans were inconsistent. 
The works of Ryder et al (2001), Houseknecht et al. (1998), Nagao et al. (2003), 
reported positive effects of CLA on IR. Ryder et al., 2001 and Houseknecht et al., 1998 
obtained a normalization of the glucose tolerance, an attenuation of the 
hyperinsulinemia and an increase in insulin sesitivity. Nagao et al. (2003) showed that 
CLA attenuated plasma glucose and insulin and prevented hyperinsulinemia by 
enhancing plasma adiponectin levels and mRNA expression.  
Moreover comparisons among the c9,t11 and t10,c12 CLA isomers in the works of 
Ryder et al. (2001) and Houseknecht et al. (2003) suggested that t10,c12 may be the 
isomer involved in beneficial effects at increasing IR levels. 
Anyway Choi et al. (2004) reported that either the intake of c9,t11 or t10,c12 alone or 
a mixture o the two could enhance the glucose tolerance, while in some other studies 
the mixed isomer of the t10,c12 and c9,t11 CLA preparation was not associated with 
insulin resistance (Riserus et al., a,b2002, 2004; Moloney et al., 2004).  
Moreover t10,c12 CLA beneficial effects were also observed in a long term-treatment 
after an initial negative effect (Wargent et al., 2005). 
In contrast the studies of Tsuboyama-Kasaoka et al. (2000), Roche et al (2002) and 
Ohashi et al. (2004) showed symptoms of lipoathrophic diabetes (mainly an induced 
IR) after CLA supplementation.  
Regarding to human studies, Riserus et al (2002 a, 2004) found a decrease in insulin 
sensitivity after the supplementation of a CLA isomer mixture or individual isomers.  
In contrast, CLA was found to improve insulin sensitivity in young sedentary humans 
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in the work of Eyjolfson et al. (2004) and an absence of negative effects of CLA on IR 
was found after long-term administration, unlike those of short-term administration 
(Whigham et al., 2004; Gaullier et al., 2004; 2005; 2007; Larsen et al., 2006; Syvertsen 
et al., 2007; Tarnopolsky et al., 2007; Watras et al., 2007; Racine et al., 2010; Sluijs et 
al., 2010), while only one study reported increased insulin levels (Gaullier et al., 2005). 
Moreover an improved glucose metabolism was reported also by Colakoglu et al. 
(2006), Gaullier et al. (2007) and Lambert et al. (2007). 
The mechanism suggested to explain the CLA effect on IR are the increase of fatty 
acid β-oxidation, and/or the effects on adipokines and cytokines (Pariza et al., 2000; 
Sugano et al., 2001; Akahoshi et al.,2002; Yang and Cook, 2003; Bhattacharya et al., 
2005; Chung et al., 2005; Park et al., 2007).  
CLA seemed to be beneficial in rat models, while it showed negative effects in mice 
and human models, which could be associated with rapid loss of fat mass together with 
hepatomegaly. Thus more studies are needed to provide a conclusion on the CLA role 
on IR in animals and human, to clarify if t10,c12 could be the only biologically active 
isomer and to define which mechanisms are involved. 
 
 
7.5 Effect against Inflammatory response 
 
Proinflammatory cytokines (TNF-α, IL-6, IL-1, etc.), anti-inflammatory cytokines (IL-
10, IFN-γ), eicosanoids (prostaglandins, leukotrienes) are some of the key 
inflammatory mediators regulated by dietary intake of PUFA. 
The effects of CLA on immune and inflammatory responses included the reduction of 
adverse effects of immune challenges, the reduction of colonic inflammation and of 
allergic type immune responses, and the modulation of the production of cytokines, 
prostaglandins, and leukotrienes (Cook et al., 1993; Miller et al., 1994; Belury and 
Kempa-Steczko, 1997; Whigham et al., 2001; Bassaganya-Riera et al., 2002; 2003; Yu 
et al., 2002; Luongo et al., 2003; Yang and Cook, 2003; Changhua et al.,2005; 
Bhattacharya et al., 2006; Hernandez-Diaz et al., 2010).  
In vitro studies suggested a CLA effect on cell proliferation: CLA significantly 
inhibited cell proliferation and increased the expression of IL-2 and IFN-γ in the work 
of Luongo et al (2003), activated PPAR-γ in RAW 264.7 cells and decreased the 
cyclooxygenase (COX) 2 and TNF-α mRNA expression (Yu et al., 2002). 
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The effect of the single isomers has not been clarified yet: in the study of Yang and 
Cook (2003) mixed isomers of CLA and c9,t11 isomer alone inhibited TNF-α 
production, while no effects were found by t10,c12 isomer; c9,t11 isomer was also 
found better than t10,c12 in inhibiting eosinophil cationic protein formation (Jaudszus 
et al., 2005), while Changua et al. (2005) concluded that inhibitory activity of CLA on 
pro-inflammatory cytokines was related to t10,c12 isomer. However bYamasaki et al. 
(2003) reported that c9,t11 isomer significantly increased TNF-a production compared 
to control and t10,c12-fed mice. 
181 study indicated that there was no difference in activity between c9,t11 and t10,c12 
isomers as far as effect on immune function is concerned.  
Studies in cancer cells showed no effect or a decrease in prostaglandin and other 
inflammatory mediators production (Park H.S. et al., 2004; Miller et al., 2001; aPark Y. 
et al., 2000; Ma et al., 2002; bKim et al., 2002). 
Animal studies reported interesting results. CLA was found effective in lowering TNF-
α and IL-6 in serum of mice (Bhattacharya et al., 2005) and Akahoshi et al. (2002) 
reported that a dietary intake of 1% CLA decreased serum TNF-α and leptin levels 
comparing to LA. In the work of aYamasaki et al. (2003) 1.5% CLA decreased serum 
TNF-α irrespective of fat content of the diet.  
Moreover pigs fed with 2% CLA, showed a reduction in growth depression, the 
prevention of production and mRNA expression of IL-6 and TNF-α, and an increase in 
PPAR-γ and IL-10 expression (Changua et al., 2005).  
Two studies by Yang et al. (2000, a2003) confirmed that CLA has some protective 
effect against down-regulating autoimmunity. In contrast, a study in rats fed with 
different diets and 1% CLA for 3 – 4 weeks reported no effects on serum levels of 
leptin and TNF-α (Sugano et al., 2001) and in the work of Tsuboyama-Kasaoka et al. 
(2000) TNF-α mRNA expression was increased by 12-fold in adipocytes isolated from 
mice fed with 1% CLA. Moreover Poirier et al. (2006) reported that the t10,c12 isomer 
induced inflammatory responses in mice white adipose tissue. 
Only few studies were conducted regarding the effects of CLA on immune function in 
humans. Moreover the effects of CLA on immune and inflammatory responses in 
humans were not consistent. 
The study of Kelley et al. showed no effect of 3.9 g/day CLA supplementation for 9 
weeks on indices of immune status of women (Kelley et al., 2000,2001). 
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A subsequent study in men showed similar findings when c9t,11 and t10,c12 CLA 
isomers, respectively in proportions 50:50 or 80:20, failed to alter immune response 
like TNF-α, IL-6, IFN-γ, IL-2, IL-4, PGE2 and lymphocyte proliferation (Albers et al., 
2003). 
Moreover Nugent et al. (2005) showed that supplementation with similar ratio of CLA 
isomers did not show any immunological benefits compared to control LA. 
In contrast Song et al. (2005), investigating the effects of 3 g/day supplementation of 
CLA (50:50 c9,t11 and t10,c12), found plasma levels of IgA, IgM and anti-
inflammatory cytokine IL-10 to be increased with concomitant decrease in levels of 
IgE, and proin- flammatory cytokines, TNF-α and IL-1h. 
Beneficial effects by CLA supplementation were also found by Albers et al. (2003) and 
Turpeinen et al. (2008). In the first work a initiation of the response to hepatitis B 
vaccination was improved by CLA supplementation (c9,t11 and t10,c12 50:50). 
Turpeinen et al. (2008) reported that the supplementation of 2 g/d c9, t11 CLA for 12 
weeks showed improved feeling of well being and less sneezing in subjects affected by 
pollen allergy (Turpeinen et al., 2008).  
In vitro and in vivo studies indicated the CLA mediatory effects on cytokine and 
prostaglandin production. It has still to be established if t10,c12 isomer could be more 
anti-inflammatory compared to c9,t11 isomer, as reported in some studies. 
Moreover clinical studies reported contrasting results. Thus further studies on humans 
are required before CLA isomers can be recommended to improve immune function. 
 
 
7.7  Bone health 
A CLA improvement on bone mass in animal models was reported, even if the effects 
were not consistent (Park et al., 1997; Watkins et al., 1997; Li and Watkins, 1998; 
Turek et al., 1998; Li et al., 1999; Park et al., 1999; Thiel-Cooper et al., 2001; Demaree 
et al., 2002; Kelly et al., 2003; Ostrowska et al., 2003; Berge et al., 2004; Kelly and 
Cashman, 2004; Weiler et al., 2004; Banu et al., 2006; Burr et al., 2006). This 
inconsistency was suggested to be due in part to the interaction between CLA and 
dietary calcium (Park et al., 2008). 
In 1999 Li et al. reported that CLA regulated bone metabolism by modulating IGF-I 
and IGFBP in young male SD rats after 42 days of treatment. Then in 2003, Kelly et al. 
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showed that the supplementation of CLA could enhance calcium absorption. 
In another study CLA supplementation for 8 weeks showed reduced bone resorption 
rates (Kelly et al., 2004). An increased bone mass was also found by Banu et al. 
(reported by Bhattacharya et al, 2006). 
Clinical studies of Kreider et al. (2002) and Brownbill et al. (2005) reported beneficial 
effects of CLA on bone mass; anyway no significant changes in the markers of bone 
turnover, bone mass and strength were found (Kreider et al., 2002; Doyle et al., 2005) 
in clinical studies.  
Moreover Racine et al. (2010) reported potential adverse effects of CLA on bone 
mineral content. 
The main mechanism involved in CLA effect on bone health might be the 
enhancement of calcium absorption, as suggested from animal and human CaCo2 cell 
studies (Roche et al., 2001; Jewell and Cashman, 2003; Kelly et al., 2003; Jewell et al., 
2005; Murphy et al., 2006; Park et al., 2006).  
Thus animal models clearly showed that CLA could increase bone mass in rats and 
mice. However no consistent results were found in the few clinical studies performed 
and further studies regarding CLA and calcium absorption are needed to determine the 
effects of CLA on bone health. 
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VIII. CLA ANALISYS 
                     
Lipid estraction  
The lipid extraction was performed according to the modified Folch’s technique 
(Christie, 1989). 30 g samples were mixed with 300 ml chloroform–methanol mixture 
(2:1, v/v); after homogenising in a Ultra-Turrax T25 homogeniser (Janke & Kunkel, 
GmbH & Co, Staufen, Germany), the mixture was agitated for 60 min and was then 
filtered into a separator funnel through filter paper (Albet folded circles, 130 cm, extra 
rapid). Seventy-five ml of saturated NaCl solution were added to the filtrate; 
chloroform phase was subsequently recovered, dehydrated with anhydrous sodium 
sulfate (Na2SO4) and dried with a rotary evaporator at 40 °C under vacuum.  
Two quantities of one hundred milligrams each (fat samples A and B) were taken from 
the fat extracted for every sample and transferred in two different glass-stoppered test-
tube of approximately 10 ml capacity for the preparation of the fatty acid methyl 
esters. 
 
Preparation of c9,t11 and t10,c12 methyl esters 
The esterification was in accordance with the method described by Bannon, Craske, & 
Hilliker (1985) with some differences. The fat samples A were dissolved in 2 ml of 
hexane solution containing an internal standard (IS, nonadecanoate methyl ester acid, 
0.3 mg m-l), whereas the fat samples B were dissolved in 2 ml of hexane solution 
without addition of IS. All the fat samples A and B were then esterified with 2N 
methanolic-potassium-hydroxide (100 µl). The mixtures were shaken vigorously for 30 
s and allowed to react for a total of 6 min at room temperature (ca. 28°C). The catalyst 
(KOH) was neutralized immediately by adding 2N hydrochloric acid (100µl) with 
shaking, to the methyl orange end-point. The hexane phase, containing the c9,t11 and 
t10,c12 methyl esters, was separated by centrifugation and subjected to gas 
chromatography. 
 
Gas-chromatographic analysis 
 c9,t11 and t10,c12 methyl esters were quantified using a GC (Varian 430) equipped 
with a flame ionization detector and a CP-Select CB capillary column for fatty acid 
methyl esters (FAME) (100 m* 0.25 mm i.d.; 0.25 mm i.d; 0.25 µm film thickness; 
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Chrompack, Varian, Inc., CA). GC oven parameters and gas variables were: isotherm 
analysis at 175°C for 65min; temperature of injection 250°C; detector temperature 
250°C; injection volume 1µl; gas carrier He and its flow rate 1.5 ml min-1. c9,t11 and 
t10,c12 isomer peaks were identified by comparison with the retention times of 
reference standards (methyl c9,t11 and t10,c12 octadecadienoate). C19:0 (IS) was 
eluted at 25.86 min, c9,t11 at 33.72 min and t10,c12 at 34.77 min. 
Since a peak overlapping with the C 19:0 (IS) was verified by previous analytical 
quality control, two GC analyses were conducted (esterified fat samples A with IS and 
B without IS) for each sample. This procedure permitted us to measure the area of the 
interfering peak which was then subtracted from the C 19:0 area to calculate the c9,t11 
and t10,c12 contents in the samples.  
The column resolves five distinguishing peaks in the CLA region on the chromatogram 
of fat: c9,t11+t7,c9+t8,c10; t11,c13+c9,c11; t10,c12; t11,t13; t9,c11 CLA isomers 
(Blasko et al., 2009; Kraft, Collomb, Mockel, Sieber & Jahreis,  2003; Kramer, 
Hernandez, Cruz-Hernandez, Kraft, Dugan, 2008). The important cis,trans isomers of 
CLA usually elute in a region of the chromatogram that is free from other fatty acids 
(Blasko et al., 2009). In our study, the co-elution of the c9,t11+t7,c9+t8,c10 triplet was 
not checked owing to commercial unavailability of the t7,c9 and t8,c10 isomer 
standards.  Nevertheless, t7,c9 and t8,c10 isomers occurrence in very low amounts in 
meat and dairy products. In fact, the t7,c9, which is the second most abundant CLA 
isomer in ruminant fat, normally can amounts up to 7% of total CLA (Kraft et al., 
2003).  Thus the hypothetical c9,t11+t7,c9+t8,c10 peak was considered only as c9,t11 
peak. 
 
The c9,t11 and t10,c12 content, expressed in mg g-1 fat, was determined by the 
following formula: 
 
CLA isomer (mg g-1 fat)=(area CLA*conc IS*CFCLA)/(areaIS*conc.fat*1.04) 
 
Where “CLA” means c9,t11 or t10,c12 isomer; ‘‘1.04’’ is the conversion factor from 
methyl ester to fatty acid and ‘‘CF’’ the isomer correction factor obtained from an 
average of 10 injections of a mixture containing 0.025g standard isomer (c9,t11 or 
t10,c12) adequately methylated and 0.010 g nonadecanoate methyl ester; and “area IS” 
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is the peak area of the C 19:0 in the fat sample A subtracted the peak area eluting at the 
retention time of the C 19:0 in the fat sample B. The CF correction factor was 
determined as follows: 
 
CFCLA=(area STD/area CLA)*(conc CLA/conc STD) 
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and II, insulin-like growth factor I and II; PPAR, peroxisomal proliferator activated 
receptor; DMBA, dimethylbenzantracene; NMU, N-nitroso-N-methylurea;  BAT, 
brown adipose tissue; WAT, white adipose tissue; SRBP, sterol regulatory binding 
protein; VEGF, vascular endothelial growth factor. 
 
1. Introduction  
The definition “Dairy food” is referred to milk and all its products, like butter, cheese, 
yoghurt and fermented products, creams.  
The dairy foods are some of the main components of the Mediterranean diet, that has 
been recognised “Unesco Asset” since the start of this year. Dairy foods are sources of 
high quality proteins and of different kinds of fats. 
A lot of studies have been carried out in the last decade about the effects of dairy foods 
constituents on human health: this article want to unify the discoveries to collect some 
global conclusions about the intake of dairy foods and human health. 
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2. Health-related components of dairy foods 
There are some dairy food components having specific roles in human health, and the 
most important are the Conjugated Linoleic Acids, the saturated fatty acids, the 
Insulin-like Growth Factor I (IGF) and the estrogens, the calcium and vitamin D. 
Conjugated Linoleic Acids (CLA) is the common name given to the family isomers of 
Linoleic Acid, a group of double-unsaturated C18 fatty acids. Among them, the most 
important isomers are the C18:2 c9,t11 CLA and the C18:2 t10,c12 CLA. These fatty 
acids belong to the ω6 group, and togheter with ω3 are a basic requirement for health: 
the first group is needed for cell walls, while the second exerts a positive effect on 
cardiovascular health and on cell structure, because they can act against atherosclerotic 
plaques. 
Beside unsaturated fatty acids, some dairy products, like whole milk and many types of 
cheeses, contain also saturated fatty acids that can have a negative role on health. 
Saturated fatty acid were recognised as one of the most important causes of 
cardiovascular diseases, dyslipidemy, and some neoplasias (Moorman et al., 2004). 
The fatty acid profile of milk could be altered by the diet of the animal, reducing 
saturated fatty acids and increasing α-linoleic acid to exert a positive role on 
cardiovascular health. 
The IGF I is a peptide also known as somatomedin C, that is usually present in in 
normal, untreated human and bovine milk. It is a potent mitogen and has a proliferative 
role in breast cancer cells in vitro (Outwater et al., 1997). 
The IGF I action is often related with the presence of estrogens: they can increase IGF-
I in breast cancer cells and IGF-I can work in synergy with them (Outwater et al., 
1997). 
Estrogens are present in milk, both in free form and in protein-bound form. Free 
estrogens have been found in commercial, pasteurized bovine milk and skim milk. 
 
 
3. Physiological role of CLA 
CLA and body weight 
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It was showed that CLA could reduce the body mass fat and increase the lean body 
mass. 
Some mechanisms involved in fat reduction were suggested: increase in energy 
expenditure and decrease in energy intake; increase of the fat oxidation; decrease of 
the adipocyte size and inhibition of some enzymes involved in fatty acid metabolism 
and lipogenesis (Bhattacharya et al., 2006). 
Some studies with purified isomers made clear that the C18:2 t10,c12 CLA isomer is 
related with the last three functions, while the C18:2 cis-9,trans-11 CLA is not 
involved and is also less powerful in increasing oxygen consumption and in energy 
expenditure. 
Uncoupling proteins (UCP) are the key regulators of the energy expenditure and it was 
suggested that UCP-2 up-regulation expression was mediated by CLA in white adipose 
tissue. Another potential mechanism explaining the increase of energy expenditure by 
CLA is the increase in catecholamines (Bhattacharya et al., 2006). 
All these studies were performed on animal models, while clinical studies showed 
positive effects of CLA supplementation in reducing body fat mass, but the magnitude 
of this improvement was lower than ones observed in animals (Bhattacharya et al., 
2006). 
 
CLA and atherosclerosis 
Another healthy function of CLA can be related to the cardiovascular system: CLA 
was suggest to be a protective molecule against atherosclerosis. 
Accumulation of lipids can induce chronic inflammation by promoting macrophage 
infiltration and activation (Stachowska et al., 2010). 
During inflammations disorders, the macrophages accumulate within the arterial 
neointima: so this fact becomes the major contributor of the atherosclerotic plaque. 
1st  stage: appearence of dysfunctional endotelial cells, whose activated adesion 
molecules and expressed chemokines recruit circulating monocytes and lymphocites 
into the intima; 
2nd stage: accumulation of LDL in the arteria wall,  where it undergoes modification by 
macrophages             these modifications increase LDL uptake by macrophages 
through the overexpression of CD36 and SRA 
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CD36 and SRA are the most important scavenger receptors on the macrophages 
surface: during inflammation, circulating LDL are taken up by macrophages through 
these receptors (Stachowska et al., 2010). 
The atherogenic plaque can be solved by the activation of PPAR (peroxisome 
proliferator activated receptors) and in particular the activation of PPARγ, that increase 
adiponectin synthesis and thus down regulate the pro-inflammatory genes (Zhang et 
al., 2011; Kadoglou et al., 2008; Delerive et al., 1999). 
The mechanisms suggested were based on the role of CLA on peroxisome proliferator-
activated receptors (PPARs), on stearoyl-COA desaturase (SCD) and on sterol 
regulatory element binding proteins (SREBPs). 
PPARs are ligand-activated nuclear receptors regulating the expression of genes that 
control lipid and glucose homeostasis. 
There are two main PPARs involved in this mechanism: PPAR α, that has a key role in 
expression regulation of genes involved in fatty acid oxidation and energy 
homeostasis, and PPARγ that induces the expression of genes that promote lipid 
storage and controls the CD36 expression, that allow the endocytose-mediated uptake 
of oxidated LDL by macrophages. 
The down-regulation of PPARγ exerted by t10,c12 isomer reduced the CD36 
macrophage receptor expression and the fat deposition in macrophages, thus reducing 
the foam cells formation (Stachowska et al., 2010). The reduction of atherosclerotic 
processes by c9,t11 CLA is instead related to a down-regulation  of pro-inflammatory 
genes (Ringseis e Eder, 2009).  
C9,t11 is more effective in modulating PPARs, while both c9,t11 and t10,c12 are 
legands for the PPAR α. 
SREBPs regulate fatty acid and triglicerids synthesis. About this hypothesis was found 
that a reduction of the synthesis and cleavage of hepatic SREBP-1 made by c9t11 
isomer positively influences lipid metabolism (Bhattacharya et al., 2006). 
Another hypothesis is related to SCD: it suggest that the SCD activity can be inhibited 
in some cases by both the c9,t11 and t10,c12 CLA isomers, making a lipid lowering 
effect (Bhattacharya et al., 2006). 
These results were obtained from animal and in vitro studies, while clinical studies 
gave disappointing results. 
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Initial studies on rabbits showed that after feeding with 14% fat (high fat) and 0,1% 
cholesterol, the CLA-fed rabbits had lower atherosclerosis in aortas. It was then 
suggested with other studies that only the t10,c12 isomer could be active against 
atherosclerosis. 
 
CLA and cancer 
Gastrointestinal cancer 
The studies made about CLA and inhibition of gastrointestinal cancer are mainly in 
vitro and animal studies. 
The clinical studies reported about the inhibition of HT-29 colon cancer cells because 
CLA induces apoptosis. In these studies the t10,c12 CLA was shown as the only agent 
acting against the cancer, inhibiting IGF-II. 
It was also found that CLA inhibits metastasis of gastric and colon cancer cells 
inoculated in mice; 1% CLA can decrease colon cancer in rats decreasing 
prostaglandins PGE2 levels. 
A Scandinavian study (Larsson et al., 2005) observed that an increase of two high fat-
dairy food portions reduced the colon cancer incidence from 4 to 13%. The authors 
only slightly attribuited this protective effect to CLA.  
Anyway, the inverse relationship between dairy product consumption and intestinal 
cancer is also reported by other epidemiological studies and a lot of factors are 
involved (pH, probiotic cultures, immuno-modulator peptides, Ca) (Elwood et al., 
2004).  
 
Breast cancer 
CLA is found to have a dual ability: act as a preventive and therapeutic agent in a 
number of rodent and human tumor model systems. 
CLA could inhibit mammary carcinogenesis by acting on normal or initiated epithelial 
cells within ducts, alveoli, terminal end buds, or on transformed epithelial cells to 
inhibit their growth, alter their differentiation, and/or to introduce cell These effects 
could be direct, via CLA delivery through blood flow, or indirect, through CLA release 
from the mammary adipocytes, and/or CLA alteration of the mammary stroma (Ip M. 
et al., 2003; Banni et al., 2001). 
In particular, CLA has been shown to inhibit rat mammary carcinogenesis induced by 
dimethylbenzanthracene (DMBA) and N-nitroso-N-methylurea (NMU): CLA was 
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found to be effective when given concurrently with the carcinogen, suggesting that one 
activity of CLA may be the inhibition of carcinogen activation (Ip M. et al., 2003) 
Dietary CLA decreases the number of epithelial target cells in the mammary gland and 
stimulates apoptosis of preneoplastic lesions (Banni et al., 2001). 
Some studies indicated that a dietary level of 0.1% CLA is sufficient to produce a 
significant inhibition of carcinogen induced rat mammary tumors (Ip C. et al., 1991) 
In one of the studies about the rat mammary carcinogenesis model, a mixed isomer 
preparation of CLA (approx. 1:1 c9,t11 and t10,c12, with minor amounts of other 
isomers) was used. The effect was dose-related: low effect at 0.05% (w/w) and 
maximum effect at a dietary level of 1% (independent of the type or level of fat in the 
diet). CLA was equally effective when provided in the form of triglyceride or free fatty 
acid. 
c9,t11 and t10,c12 isomers of CLA were found to be equally effective in inhibiting the 
development of NMU-induced preneoplastic lesions and tumors in the mammary 
gland, and the equal efficacy of the two isomers was then confirmed in a mammary 
metastasis study (Ip M. et al., 2001). 
The results of some diets are described in table 1. 
It was tried to compare different experiments in an observational way. 
 
Table 1. CLA dose effect (g/100 g diet) on breast cancer incidence in rats. Values 
within the same row were provided in different studies using the same CLA 
concentration. 
Cla concentration in 
diet (%) 
CORRECTED INCIDENCE % 
0 100         
0,05 103,57a         
0,1 75a 128,57b 91,43c     
0,25 60,71a 114,29b 85,71c     
0,5 75,03a 64,29a 65a 53,57b 57,14c 
0,8 53,57d 57,14e 60,71f     
1 53,59a 43,75a       
1,5 50,05a 37,5a       
a
c9,t11 (42%)+ t10,c12 (46%)  (Hubbard et al., 2003) 
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b
c9,t11 only 
c
t10,c12 only 
d
c9,t11 92% (Jiang et al., 2009) 
e
c9,t11 + c9,c11 (Jiang et al., 2009) 
f 
c11,t13 + c9,t11 + t10,c12 + t8,c10 (Jiang et al., 2009) 
 
The relation between CLA intake and breast cancer incidence is showed in the figure 
below. Cancer incidence is inversely related to CLA intake as long as 0.25% level of 
CLA supplementation. Higher levels than 0.25% did not improved the anti-tumoral 
effect of CLA. 
  
 
 
 
 
 
 
 
 
A recent study showed that a mixed CLA preparation markedly change the 
composition of the mouse mammary fat pad, an effect that is completely due to the 
t10,c12 isomer (Masso-Welch et al., unpublished data cited in Ip M. et al., 2003). In 
this study a CD2F1 mouse was fed t10,c12 CLA at levels of 0.5 and 1.0% in the diet 
and the results were the complete abrogation of the brown adipose tissue (BAT) 
component of the mammary fat pad, and the significantly reduction of the white 
adipose tissue (WAT) compartment. 
This is the result of the induction of apoptosis, that can be a consequence of the 
marked induction of apoptosis of capillaries into the BAT and WAT. 
No increase in apoptosis of mammary adipocytes, or the stromal capillaries, was 
instead noted in mice fed the c9,t11 CLA isomer. Indeed, when fed at the 1% level, the 
c9,t11 CLA isomer increased the proportion of BAT in the mammary gland, maybe 
due to the CLA stimulatory effect on the adipogenic differentiation of the multipotent 
stromal-vasculare cells in the mammary gland (Ip M. et al., 2003). 
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It was found that the two main CLA isomers have different mechanism to inhibit the 
cell proliferations (Chujo et al., 2003; Hubbard et al., 2003) 
The mechanism by wich CLA inhibits mammary carcinogenesis includes the action on 
the vascular endothelial growth factor VEGF-A. 
VEGF is a cytokine that is known to stimulate vascular permeability and migration, 
proliferation and apopthosis of endothelial cells: it can increase the invasiveness and 
the growth of breast cancer cells. 
A mix of the CLA isomers can decrease the VEGF serum levels and can act against 
one of the VEGF receptors, affecting the mammary carcinogenesis directly on 
epithelium and indirectly acting against the angiogenesis (Masso-Welch et al., 2002; Ip 
M. et al., 2003). 
In vitro studies showed that CLA is cytotoxic and induce lipid peroxidation in MCF-7 
cell line (human breast cancer cells). 
CLA at a concentration 3.5 × 10−5 M selectively inhibits proliferation of ER (estrogen) 
positive MCF-7 cells as compared with ER negative MDA-MB-231 cells. Cell cycle 
studies indicated that a higher percentage of CLA treated MCF-7 cells remained in the 
G0/G1 phase as compared to control and those treated with linoleic acid (LA). Many 
anti-estrogens are known to possess this property and are able to block the cell cycle at 
the G0/G1 phase. 
Results indicated that MCF-7 cells grown with CLA for 4 days began to proliferate 
upon their return to normal media: the growth inibitory action of CLA on these cells is 
reversible. 
Isomer t10,c12 CLA inhibits cell proliferation if induced by insulin and estrogen, while 
c9,t11 CLA has a different mechanisms to inhibit cell proliferation. In the absence of 
CLA, or upon its withdrawal from media, the normal mitogenic pathway continues to 
operate resulting in increased proliferation of cells. 
In a recent study has been shown that CLA isomers down regulate estrogen receptor 
alfa expression both at mRNA level and at protein level, and reduce the link between a 
nuclear protein and a estrogen response element. Thus, CLA isomers have significant 
antiestrogenic properties (Bhattacharya et al., 2006). 
Focusing on these experimental results it can be hypothesized that CLA inhibits MCF-
7 cell growth by interfering with the hormone regulated mitogenic pathway (Durgam et 
al., 1997). 
Clinical studies gave contrasting results. 
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In some cases it was reported that an increased CLA intake via whole milk decreased 
the risk of breast cancer in women, and it was further shown that dietary CLA is also 
effective in the prevention of DMBA induced mammary tumors (Aro et al., 2000; 
Knekt et al., 1996); in other cases CLA content in diet was not associated with a lower 
risk of breast cancer (Voorrips et al., 2002). 
 
Prostate cancer  
It was shown that CLA has a antiproliferative effect in vitro and in vivo. Some in vitro 
studies showed that the t10,c12CLA is more useful than c9,t11 against prostate cancer. 
The in vivo experiments are few, but a decrease in tumoral metastasis in animals 
locally injected with cancer cells and fed CLA was observed, while no difference could 
be detected in control animals. 
 It was suggested that the mechanism by which CLA can inhibit the prostate cancer 
consisted mainly in modulating the apoptosis and the cell cycle as it was refrerred also 
about breast cancer and gastrointestinal cancer. 
The actions of CLA isomers are direceted on different molecules: t10,c12 CLA can 
modulate the genes involved in apoptosis and in cell cycle control, while c9,t11 CLA 
can regulates some genes involved in arachidonic acid metabolism, thus attenuates the 
eicosanoid synthesis. 
CLA isomers can infact reduce the COX and LOX gene expression (c9,t11), related to 
the arachidonic acid methabolism; they can decrease bcl-2 expression and induce 
apoptosis in PC3 cells, thus regulating cell cycles and apoptosis (Ochoa et al., 2004). 
 
Angiogenesis 
One important action of both CLA isomers against cancerogenesis is based on the 
control of angiogenesis. 
Some in vivo studies reported that both the isomers can decrease VEGF serum levels 
and Flk-1 protein in the mammary gland, due to control angiogenesis. 
It was also shown that both 1%CLA and 2% CLA diets significantly decrease 
angiogenesis, without a significant difference from each other, not only acting on 
VEGF, but also inhibiting the formation of functional blood vessels (Masso-Welch et 
al., 2002). 
To understand the CLA inhibition of angiogenesis some mechanisms were 
hypothesized:  
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1) decrease of the initial negative cellular alterations and angiogenic functional blood-
vessels; 2) reduction of the cellular network; 3) inhibition of microcapillary networks 
in vitro; 4) regulation of  systemic and local VEGF and its receptors. 
Some studies also underlined the presence of another potential mediator of CLA 
effects against angiogenesis. It was infact shown that leptin, a proangiogenic hormone, 
decreased in plasma levels with the administration of t10,c12 CLA. 
 
CLA and insulin resistance  (IR)  
CLA attenuated plasma glucose and insulin and prevented hyperinsulinemia by 
enhancing plasma adiponectin levels and mRNA expression in white adipose tissue 
from ZDF rats. 
Only long term treatment could improve insulin sensitivity and glucose tolerance, 
while at first the CLA treatment may have a bad effect on IR (Bhattacharya et al., 
2006). 
Some clinical studies showed that the t10,c12 CLA induces hyperinsulinemia in obese 
individuals, while in other studies CLA was found improving insulin sensivity 
(Bhattacharya et al., 2006). 
 
CLA and anti-inflammatory response 
Either CLA and CLNA have a benefical effect on inflammations: 
- down regulation of eicosanoid production 
- increase of PPAR mediated anti-inflammatory response 
- suppression of inflammatory response through the regulation of cell transcription 
factor nuclear factor k B (NF-kB) 
- reduction of expression of pro-inflammatory proteins (TNF-α; Leukin) 
In animals CLA induce negative regulation of the expression of proinflammatory 
genes and activation of apoptosis in the atherosclerotic lesion [4]. 
 
CLA intake 
According to Kelley et al. (2007) the intake of CLA in humans, corresponding to the 
effective levels in animals range from 5 to 50 g/day. A recent paper from Mushtaq et 
al. (2010) reported a daily intake of 97,5 mg in 18 british volunteers, while Aro et al. 
(2000) estimated a CLA intake in finnish women from 126.8 to 142.3 mg/day. Data on 
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CLA intake by italian population are not available, however on the basis of these two 
works (Aro et al., 2000; Mushtaq et al., 2004), we need to increase CLA content in 
milk and dairy foods as a tool to make available foods that fit well with the need of a 
more and more health-conscious consumer.  
 
 
4. Phisiological role of saturated fatty acids 
A large intake of dairy food can mean a high introduction of fat, expecially in terms of 
saturated fatty acids (Moorman et al., 2004) and cholesterol. 
The negative effects of this type of fat can be mainly two: the increase in LDL and in 
cardiovascular problems, and the increase in circulating estrogen concentration. 
 In the Seven Countries Study was reported that a high saturated fat intake was in 
strong relationship with coronary death rates. 
In other studies was also discovered that different saturated fatty acid had different 
effects on LDL levels: while stearic acid (18:0) does not affect cholesterol levels if 
compared with monounsaturated oleic acid (18:1), the saturated fatty acid shorter than 
C18, like C14 and C16 tend to increase plasma levels of cholesterol and LDL. 
It was thus shown that replacing the saturated fats with poli-unsaturated ones was 
clearly effective in lowering serum cholesterol, and so in reducing the risk of coronary 
heart diseases (Hu et al., 2001). 
 
5. Phisiological role of insulin-like growth factor and estrogens 
Estrogen and IGF-I are present in human and bovine milk, in free and bound form, 
they cannot be destroyed with pasteurization and they can only be reduced with milk 
filtration. 
Insulin like growth factor IGF-I and IGF-II, also known as somatomedin C and A, are 
peptides acting as growth factor in local tissues. 
They are suggested to be potent mitogens, normally present in human and bovine milk. 
It was reported that the bovine GH administration to dairy cows increases the 
concentration of IGF-I in milk (Outwater et al., 1997). 
The IGF-I is supposed to be a contributor to breast cancer cells proliferation, because 
of its action on the IGF-I receptors and binding proteins. Some in vitro studies revealed 
that breast cancer cells respond to nanomolar concentrations of IGF-I and it was shown 
Manuscript 1: Dairy foods and health 
 58
that these neoplastic cells have more receptors for IGF-I than the normal mammary 
tissue. 
IGF-I also causes changes in cell cycle and oncogenes like c-fos. 
The direct consequence of these IGF-I actions may be the non-controlled growth of the 
cancer. 
Some other studies reported again that IGF-I is involved in cell transformation because 
removing or blocking its receptors can eliminate viral or cellular oncogene-induced 
malignant transformation (Moorman et al., 2004). 
It has to be considered that IGF-I can work in synergy with other growth factors, 
making the transformed cells more responsive to their signals. 
The estrogens have the best synergy with IGF-I: they were found to increase the IGF-I 
level in human breast tissue and IGF-I was called estromedin itself, because it mediates 
the estrogen effects. 
In some studies an high plasma level of estrogen was linked with breast cancer 
incidence (Outwater et al., 1997; Moorman et al., 2004). 
Thus IGF-I can stimulate the growth of human breast cancer cells, acting in sinergy 
with estrogens. 
Another important consideration leads to the absorption of IGF. 
Intact IGF-I can be absorbed by the gastro-intestinal tract and can travel through the 
bloodstream, exerting its mitogenic effects on local tissues, so the concerns about this 
peptides are not only related to the IGF-I already present in our body or produced 
thanking to the estrogen, but also to the growth factors introduced by whole milk 
intake. 
 
6. Phisiological role of Calcium and Vitamin D 
Calcium and vitamin D are strictly related each other: vitamin D regulates Ca 
absorption and metabolism. Much of the evidence showing the protective role of Ca 
against cancer are related to linkages with the vitamin D. 
It was shown that the active form of vitamin D markedly affects cell growth processes 
and development; then it was also reported about a specific role of this molecule in the 
differentiation of the mammary gland (Moorman et al., 2004). 
Vitamin D can in fact inhibit the proliferation of cell cycle, arresting it at phase G0/G1, 
like CLA. In this way it can down-regulate several promoting factors as IGF and up-
regulate some negative growth factors. 
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Then the vitamin D can also exert a regulation of the cell cycle, inducing apoptosis, 
cell shrinkage, chromatin condensation and DNA fragmentation (Moorman et al., 
2004). 
The alone Ca effects are not so evident: in some studies was shown that the inverse 
relation between calcium and cancer was statistically significant only at the highest 
vitamin D intake (Cho et al., 2004) but it was shown that also Ca in itself has an 
apoptotic effect, thus protecting against the cancer (Alvarez-Leon et al., 2006; 
Moorman et al., 2004). 
 
 
7. Conclusion 
A lot of studies were carried out to find whether an inverse relation between dairy 
foods and cancer could be demonstrated. 
Many studies showed the inverse relation between dairy foods intake and cancer (Cho 
et al., 2004; Knekt et al., 1996). 
We have to discriminate between different types of cancer. Milk was revealed as a 
protective factor against colorectal cancer in some articles (Knekt et al., 1996; Alvarez-
Leon et al., 2006; Moorman et al., 2004; Cho et al., 2004). 
In one of these experiments was discovered that an increase of 500g/day in milk 
consumption was associated with a 12% reduced risk of colorectal cancer. 
Some studies showed the protective effects of dairy foods against breast cancer (Ip C. 
et a., 1996; Knekt et al., 1996;Shin et al., 2002; Cho et al., 2004) expecially about 
fermented products: it was underlined the absence of any positive relation between 
fermented milk and dairy products and breast cancer risk (Van’t Veer et al., 1989). 
The observational analysis we have done showed that, comparing some animal studies, 
a trend can be found between breast cancer risk and intake of CLA. 
Unfortunately not enough clinical studies are available to prove the same trend on 
humans.  
In few studies the protective effects of dairy foods against this kind of cancer cannot be 
demonstrated, and was instead found a positive relation between the two (Voorrips et 
al., 2002; Alvarez-Leon et al., 2006). 
In dairy foods the concurrent presence of some health protective factors and negative 
factors is clear. 
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Thus the epidemiologic studies nowadays are not able to establish which of these 
factors is the more relevant for human health. 
It can be shown that some studies revealed positive effects of dairy foods that cannot 
be statistically demonstrated and some results cannot be clearly connected with a 
specific component of these foods. 
Concluding we can say that dairy foods are essential for body metabolism and some 
components are probably involved in healthy processes. 
The major effects against cancer are related to the synergy between CLA, vitamin D 
and calcium. 
These molecules can also be involved in other healthy effects, like prevention against 
atherosclerosis, fat body mass reduction and insulin resistance control. 
The CLA isomers have different targets and mechanisms of action, but they can surely 
regulate cells proliferation and estrogens or growth factors effects. 
The overview on these results thus suggests that dairy foods (with a correct intake) are 
important to protect us against some of the main concerns of our times, but other 
studies are needed to say that they are surely safe, even their high saturated fat content. 
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Abstract 
The aim of the work was to complete data obtained in previous studies with a survey 
on cis9,trans11 (c9,t11) and trans10,cis12 (t10,c12) conjugated linoleic acid (CLA) 
content in cheeses collected from Italian large-scale retail trade. This is an integrative 
part of a whole study characterizing food CLA content, with objective of estimating 
daily CLA intake of Italian consumers. Among the sampled cheeses (n=102), 
Gruyere and Feta (10.21 and 8.50 mg g-1fat, respectively) had the highest (P<0.05) 
c9,t11 contents. Furthermore, cheeses with long-ripening period (>180 d) showed 
higher c9,t11 values than those with a shorter maturation period. The t10,c12 CLA 
isomer was almost absent, being detected only in Gruyere,  Stracchino, Robiola, 
Philadelphia and Scamorza, with values up to 0.4 mg g-1 fat. These data improved the 
knowledge about CLA content of dairy products, and this could make an accurate 
estimate of CLA ingested by Italian consumers. 
 
 
1. Introduction 
Conjugated linoleic acid (CLA) is the collective name for a group of linoleic acid 
isomers with conjugated double bonds. The main health-benefical CLA isomers are 
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the cis9,trans11 (c9,t11) and the trans10,cis12 (t10,c12), with the first playing a 
protecting role against cancer and atherosclerosis (Bhattacharya et al., 2006) and 
attenuating insulin resistance (Taylor & Zahradka, 2004), whereas the latter are 
related to the increase in energy expenditure and fat oxidation, decrease of adipocyte 
size and inhibition of some enzymes of fatty acid metabolism and lipogenesis 
(Bhattacharya et al., 2006). As reported by Ip, Singh, Thompson and Scimeca (1994), 
a recommended daily CLA intake of 3 g day-1 was recommended to reduce cancer 
risk. Anyway the authors did not specify to which isomer the recommendation 
referred. Successively, Ip et al. (1999) concluded that the main effect in reducing the 
mammary cancer risk could be imputed to the c9,t11 isomer. 
One of the main sources of CLA for humans is milk and dairy products (i.e., yogurt, 
fermented milk, soft and hard cheeses, etc.). It is well know the main factor affecting 
final CLA content of milk is animal feeding strategy. In particular, milk from 
lactating dairy cows fed fresh forage has a higher CLA content than milk from silage-
fed cows (Chilliard & Ferlay, 2004). Otherwise, the milk processing and storage 
conditions generally do not affect the CLA concentration of milk fat (Bisig, 
Eberhard, Collomb, & Rehberger, 2007). 
To provide information about CLA content of different dairy products available for 
consumers, different works were previously published by our research groups 
(Prandini et al., 2001; Prandini, Sigolo, Cerioli, & Piva, 2009; Prandini, Sigolo, & 
Piva, 2009; Prandini, Sigolo, & Piva, 2011; Prandini, Sigolo, Tansini, Brogna, & 
Piva, 2007). Nevertheless, not one complete database about CLA content in 
commonly marketed fresh and ripened cheeses is currently available to our 
knowledge. Thus, the aim of the present work was to complete the data obtained in 
previous studies with a survey on the c9,t11 and t10,c12 CLA content in cheese 
typologies collected from Italian large-scale retail trade (LRT) and not still 
characterized for these parameters. This is an integrative part of a extend work, 
studying the CLA content in foods, with the objective of estimating the daily CLA 
intake in an Italian cohort.  
 
2. Materials and Methods 
2.1 Sampling 
A total of 102 samples of cows’ milk cheese (except Feta) were collected from Italian 
LRT during a one-year period, from January to December 2011 to cover the 
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possibilities of consumer purchase. Cheese produced with milk from the spring and 
summer period by pasture-fed animals was avoided, in order to reduce CLA variation 
due to the animal diet. For each sampled cheese, the evaluation was based on 
ripening period and on information provided on the label (milk species, microbial 
starters, shelf life).  
 
2.2 Chemical analysis 
The moisture, fat, protein (total nitrogen x 6.38) and carbohydrate contents were 
determined in accordance with International Dairy Federation (IDF) 4:2004, 
221:1998, 20-1:2001 and 79-2:2002 methods, respectively.  
The lipid extraction was in agreement to Folch’s technique (Christie, 1989) as 
modified by Prandini et al. (2007). Then, two 100-mg quantities (fat samples A and 
B) were taken from the fat extracted for every cheese sample and transferred in two 
different glass-stoppered test-tube of approximately 10 mL capacity. The preparation 
of c9,t11 and t10,c12 methyl esters was conducted in accordance with the method 
described by Prandini et al. (2007) on the fat samples A by using an internal standard 
(IS, nonadecanoate methyl ester acid, 0.3 mg mL-1; Sigma-Aldrich Inc. Pleasant Gap, 
PA, USA) and on the fat samples B without addition of IS. c9,t11 and t10,c12 methyl 
esters were quantified using a GC (Varian 430) equipped with a flame ionization 
detector and a CP-Select CB capillary column for fatty acid methyl esters (100 m* 
0.25 mm i.d.; 0.25 mm i.d; 0.25 µm film thickness; Chrompack, Varian, Inc., Palo 
Alto, CA, USA). GC oven parameters and gas variables were: isotherm analysis at 
175°C for 65 min; temperature of injection and detector 250°C; injection volume 
1µL; gas carrier He and its flow rate 1.5 mL min-1. c9,t11 and t10,c12 isomer peaks 
were identified by comparison with the retention times of reference standards (methyl 
c9,t11 and t10,c12 octadecadienoate; Matreya, Pleasant Gap, PA, USA). A peak 
overlapping was found for C19:0 (IS), thus the area of the interfering peak was 
measured injecting each sample with and without IS; this area was then subtracted 
from C19:0 area to calculate the c9,t11 and t10,c12 contents in the cheese samples. 
The c9,t11 and t10,c12 levels were expressed in mg g-1 of fat. 
In our study, the co-elution of the c9,t11+t7,c9+t8,c10 triplet (Blasko et al., 2009) 
was not checked owing to commercial unavailability of the t7,c9 and t8,c10 isomer 
standards.  Nevertheless, these isomers occur in very low amounts in milk fat (Kraft, 
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Collomb, Mockel, Sieber, & Jahreis, 2003). Thus, in our work the hypothetical 
c9,t11+t7,c9+t8,c10 peak was easily named c9,t11 peak. 
 
2.5 Statistical analysis 
Data were analyzed using parametric one-way ANOVA by GLM procedure of SAS 
(version 9.3, 2010), except for non-normal distributed CLA t10,c12, that were 
analyzed using Kruskal–Wallis non parametric ANOVA. The fixed tested effects 
were cheese type (n=16), curd cooking (n=3), texture (n=3) and ripening time (n=4). 
The least significant difference was generated from Tukey’s test and it was used as 
the basis of the multiple comparisons among means, except for CLA t10,c12 means 
that were compared with Behrens Fischer non parametric multiple comparison test. 
The significance level was set as P < 0.05. 
 
3. Results and Discussion 
From a nutritional point of view, improving the knowledge on CLA content of foods, 
in particular dairy products, could improve the estimate of CLA ingested by 
consumers. Furthermore, this could be useful to reduce the gap between RDI and 
effective amount of CLA assumed by humans, providing revised nutritional 
guidelines. The present study was based on a random sampling of main cheeses sold 
by Italian LRT and it was not possible to obtain any information about CLA content 
of the original milk. 
Table 1 displays the chemical composition and c9,t11 and t10,c12 CLA isomer 
contents. As expected, fresh cheeses (Belpaese, Stracchino, Robiola, cows’ milk 
Ricotta, Feta, Crescenza, Philadelphia) contained more moisture (P<0.05) and 
consequently less fat (P<0.05) and protein (P<0.05) than ripened cheese.  
Gruyere and Feta had the highest c9,t11 contents (P<0.05). The high c9,t11 level in 
Gruyere could be due either to the ripening period or the use of Propionibacterium 
spp. starters. Kim et al. (2009) reported that long-ripened cheeses contain more CLA 
than others. Accordingly, the highest (P<0.05) c9,t11 CLA isomer level was observed 
in long-ripening cheeses (>180 days, table 2). Furthermore, Gruyere contains 
Propionibacterium spp., a starter already known as CLA promoter (Jiang, Bjorck, & 
Fonden, 1998). Sieber, Collomb, Aeschlimann, Jelen, and Eyer (2004) reviewed the 
impact of microbial cultures on CLA content, suggesting that CLA is produced from 
linoleic acid through the action of primary or secondary cultures used in cheese 
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processing. In particular, Jiang et al. (1998) reported the Propionibacteria spp. ability 
to convert up to 90% of free linoleic acid in total CLA (c9,t11; t10,c12; t9,t11; 
t10,t12). This finding was in accordance with those of Alonso, Cuesta and Gilliland 
(2003), Coakley et al. (2003), Kim and Liu (2002) and Kishino, Ogawa, Ando, 
Omura and Shimizu (2002) showing that defined strains of Lactobacilli spp., 
Bifidobacteria spp. and Propionibacteria spp. were able to convert efficiently linoleic 
acid to CLA. However, in order to study the factors that might affect the c9,t11 CLA 
level in cheeses, the whole production system should be carefully checked. 
Feta is a typical Greek cheese made from ewes’ milk or from a mixture of ewes’ and 
goat milk (≤ 20%) (Salvadori del Prato, 2001) and this can explain the high c9,t11 
level found in Feta (Table 1) since ewe’s milk has more CLA than cows’ milk 
(Jahreis et al., 1999).  
The c9,t11 content of sampled cheeses (5.77±1.57 mg g-1 fat; range 4.32-10.21 mg g-1 
fat) was similar to those obtained by Nunes and Torres (2010) and Jiang, Björk and 
Fondén (1997) in Brazilian and Swedish dairy products, respectively. Lower values 
were found by Lin, Boylston, Luedecke, and Shultz (1998), Ma, Wierzbicki, Field 
and Clandinin (1999) and Seckin, Gursoy, Kinik and Akbulut (2005) in US, Canadian 
and Turkish cheeses, respectively, whereas higher levels were reported for cheeses 
sampled in France (Lavillonniere, Martin, Bourgnoux and Sebedio, 1998), the Azores 
(Pestana et al., 2005) and Greece (Zlatanos, Laskaridis, Feist and Sagredos, 2002). 
Furthermore, t10,c12 CLA isomer was almost absent, being detected only in Gruyere 
(Table 1) and in trace in other cheeses (i.e., Stracchino, Robiola, Philadelphia, 
Scamorza), with values ranging from 0.1 to 0.4 mg g-1 fat. Higher t10,c12 CLA 
amounts were found in Greek and Canadian cheeses (Ma, Wierzbicki, Field and 
Clandinin, 1999; Zlatanos et al. 2002), while it was not detected in Azorean ones 
(Pestana et al., 2005). 
 
4. Conclusion 
Comparing our results with data from other countries, differences were found in 
c9,t11 and t10,c12 isomer contents, thus suggesting that CLA food data produced on 
a National scale should be provided to implement knowledge concerning the potential 
CLA intake used in epidemiological studies. 
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Table 1. Average (± standard deviation) chemical composition (g/100g) and c9,t11 and t10,c12 CLA isomer 
concentrations (mg g-1 fat). 
Cheese na  Moisture  Fat  Protein  Carbohydrate 
c9,t11 
CLA 
t10,c12 
CLA 
All samples 102        
Provola     6  43.89±6.01 27.08±4.47 24.55±1.82 2.00±0.20 6.96±5.12 n.d. 
Provolone     6  40.02±2.14 30.33±1.47 24.48±1.71 2.00±0.15 4.92±0.23 n.d.  
Caciotta     6  45.20±3.77 28.58±3.29 23.80±4.97 0.70±0.21 5.98±1.18 n.d.  
Gouda     6  40.47±2.47 28.83±3.04 20.61±4.73 0.03±0.01 4.32±1.43 n.d.  
Montasio     6  34.17±2.31 35.00±1.48 25.66±1.32 0.02±0.01 4.78±1.23 n.d.  
Gruyere     6  38.30±0.89 34.92±0.92 27.44±0.87 0.50±0.02 10.21±2.47 0.40±0.63 
Asiago 12  38.97±4.51 31.42±1.47 24.80±2.23 0.50±0.09 5.91±1.95 n.d. 
Caciocavallo     6  36.70±2.14 29.50±2.21 31.77±2.42 2.30±0.23 5.35±2.77 n.d. 
 Belpaese     6  50.10±6.93 24.42±4.99 20.07±3.18 2.50±0.20 5.22±1.97 n.d. 
Stracchino     6  56.86±2.92 25.33±3.61 12.93±3.58 2.40±0.19 5.01±1.26 0.14±0.33 
Robiola     6  57.06±2.83 33.58±3.37 7.85±1.85 1.50±0.16 4.77±1.16 0.17±0.41 
cows’ Ricotta     6  75.37±3.24 10.67±1.94 8.53±2.27 3.50±0.28 5.53±1.08 n.d. 
Feta     6  53.09±1.25 26.67±1.47 17.31±0.81 0.70±0.04 8.50±1.95 n.d. 
 Crescenza     6  60.49±4.97 21.67±6.70 15.64±1.66 1.80±0.17 4.76±0,79 n.d. 
Philadelphia     6  65.93±8.13 22.29±10.59 8.68±1.75 3.10±0.21 5.41±1.15 0.16±0.38 
Scamorza     6  51.45±2.26 20.83±2.07 22.60±1.33 0.50±0.03 4.93±0.31 0.16±0.39 
√MSEb   4.100 4.069 4.220 1.654 2.025 0.238 
P   <0.05 <0.05 <0.05 <0.05 <0.05 n.s. 
LSDc   8.223 8.162 8.465 0.80 4.063 - 
n.d., not detected; n.s., not significant. 
n
a= number of samples. 
√MSEb = root mean square error. 
LSDc= least significant difference . 
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Table 2.  Mean cheese c9,t11 CLA isomer content (mg g-1 fat) considering manufacturing parameters 
(curds cooking, moisture content, ripening and seasoning). 
 
 na  Mean ± SD P √MSEb LSDc 
Category 102      
Curds cooking       
Raw 48  5.77±2.40    
Semicooked 30  5.53±1.59 n.s. 2.391 - 
Cooked 24  6.16±3.10    
Moisture Texture        
Hard 30  6.43±2.82    
Semi-hard 24  5.55±2.87 n.s. 2.366 - 
Soft 48  5.52±1.69    
Ripening       
fresh ( <45 days) 68  5.70±2.18    
medium (45<days<90) 15  4.85±1.92  <0.05 2.241 2.241 
mid-long (90<days<180) 10  5.45±2.03    
long ( >180 days) 9  8.45±3.28    
n.s., not significant. 
n
a= number of samples. 
√MSEb = root mean square error. 
LSDc= least significant difference.  
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Abstract  
Conjugated linoleic acid (CLA) isomers are considered healthy factors due to their 
anticarcinogenic and anti-atherosclerotic properties, as well as lipolytic effect. 
Recommended daily intakes of 3 g CLA/day/person has been proposed to obtain 
biological effects in humans. The aim of this work was to provide data on cis9,trans11 
(c9,t11 CLA) and trans10,cis12 (t10,c12 CLA) contents in meats collected from Italian 
large-scale retail trade (LRT) and completing a food CLA database. In a first study, 
beef loin meats (n= 42), sampled from Italian markets, were characterized for some 
information available for consumers by labelling: origin (i.e., Ireland, France-Italy, 
Piedmont) and sex of animals. No differences were observed for c9,t11 and t10,c12 
CLA contents of loin meat from male or female. Piedmontese meat showed lower 
(P<0.05) c9,t11 CLA level than Irish and French-Italian meats, whereas similar t10,c12 
CLA contents were measured in Piedmontese, Irish and French-Italian meats. 
Successively, a total of 84 samples of meats from different animal species were 
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collected from Italian LRT and characterized for their contents in c9,t11 and t10,c12 
CLA. They were: male beef (18), female beef (19), veal (15), lamb (6), pork (7), horse 
(6), belly beef (6) and canned beef meat (7). Lamb meat had the highest (P<0.05) 
c9,t11 CLA content. The c9,t11 CLA was lower than 2 mg/g fat in veal, pork and horse 
meats. Low t10,c12 CLA amounts were found in all analyzed meat samples. These 
data provided information to estimate the average daily intake of CLA from meats in 
an Italian cohort which can be used in epidemiological studies. 
 
Key words: cis9,trans11 CLA, trans10,cis12 CLA, Meat, Italian market, Animal 
origin.  
 
Introduction  
The term CLA refers to a group of conjugated isomers of linoleic acid which have 
been considered potent cancer preventive agents (Ip et al., 1994). Meat and dairy 
products are the main sources of CLA in human diet. CLA is produced by either 
ruminal biohydrogenation of dietary linoleic and linolenic acids to stearic acid or by 
endogenous synthesis from trans-vaccenic acid via ∆9-desaturase (Griinari and 
Bauman, 1999; Griinari et al., 2000). Consequently, food sources derived from 
ruminants are significantly richer in CLA than those from monogastric animals 
(Schmid et al., 2006). CLA content in meat is affected by diet, animal and post-harvest 
related factors (Khanal and Olson, 2004; Dhiman et al., 2005). In particular, 
manipulation of animal diets can increase CLA content in meat, both from ruminant 
and non-ruminant. Feeding strategies, addressed to enhance CLA content in ruminant 
meat, are mainly based on supplementation of linoleic or linolenic acid as substrates 
for rumen biohydrogenation (Griswold et al., 2003; Sackman et al., 2003). 
Incorporation of CLA and trans-vaccenic acid in the animal diet could increase CLA 
concentration in non-ruminant meat (Glaser et al., 2002; Teschendorf et al., 2002).   
The CLA importance is related mainly to the healthy properties of two isomers, being 
cis9,trans11 CLA (c9,t11 CLA) and trans10,cis12 CLA (t10,c12 CLA) (Bhattacharya 
et al., 2006; Benjamin and Spener, 2009; Churruca et al., 2009; Stringer et al., 2010). 
Effects against mammary and prostate carcinogenesis, atherosclerosis (Bhattacharya et 
al., 2006) and insulin resistance (Taylor and Zahradka, 2004) have been attributed to 
c9,t11 CLA. A recommended daily CLA intake of 3 g/d to reduce cancer risk was 
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reported by Ip et al. (1994). In a successive study, Ip et al. (1999) attributed main 
effect in reducing the mammary cancer risk to the c9,t11 CLA isomer. Furthermore, 
the t10,c12 CLA has been reported as CLA isomer responsible for improving features 
of the metabolic syndrome, such as hepatic steatosis, glucose intolerance and 
inflammation (Stringer et al., 2010). As a matter of fact, recommendation should be 
referred more properly to consumption of these isomers rather than all CLA isomers.    
The aim of this work was to determine c9,t11 and t10,c12 CLA contents in meats 
available from Italian large-scale retail trade (LRT). In a first study (FS), the contents 
of these two CLA isomers in beef loin meats were related to different sex and origin of 
animals, on the base of meat label information. Then, a survey study (SS) was carried 
out to assess c9,t11 and t10,c12 CLA contents and chemical composition in meats 
from different animal species (ruminant and non-ruminant). The current studies 
represented an integrative part of an extended work conducted for studying the c9,t11 
and t10,c12 CLA contents in foods (Prandini et al., 2001, 2007, 2009a, 2009b, 2011; 
Cicognini et al., 2013) and estimating the daily CLA intake in an Italian cohort, 
making them available for epidemiological studies. 
  
Materials and Methods 
Sampling 
All the meat samples were purchased at supermarket in pre-wrapped food trays during 
a one-year period (from January to December 2011). 
In FS study, male and female beef loin meats of three different origins (Piedmont, 
Ireland and French-Italy) were collected from Italian LRT. In particular, 14 samples 
were analyzed for each origin, of which 7 were female (heifer beef) and 7 male, for a 
total of 42 samples.  
In SS survey, a total of 84 samples of ruminant and non-ruminant meat were 
collected from Italian LRT as follows: male beef (steers; 18); female beef (19); lamb 
(6); belly beef (6); veal (15); pork (7); horse (6); canned beef meat (7). 
 
Chemical analysis 
All meat samples were ground immediately after purchase with a mincing machine 
“La Moulinette 750 W” (Moulinex, France). The samples were then vacuum packaged 
and stored at -18°C and defrosted at room temperature before analysis. 
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The moisture was determined in accordance with the UNI ISO 1442:2010 method 
(ISO, 2010). Fat content was determined with the UNI ISO 1443:1991 method (ISO, 
1991). Protein content was measured in accordance with the UNI ISO 937:1991 
method (ISO, 1991). A N-protein conversion factor of 6.25 was used.  
The lipid extraction was performed according to Folch’s technique (Christie, 1989) 
as modified by Prandini et al. (2007). The preparation of c9,t11 and t10,c12 CLA 
methyl esters was conducted in accordance with the method described by Prandini et 
al. (2007) on two 100-mg amounts of fat extracted (with and without addition of 
internal standard; IS, nonadecanoate methyl ester acid, 0.3 mg/mL; Sigma-Aldrich Inc. 
Pleasant Gap, PA, USA) for each meat sample. The c9,t11 and t10,c12 CLA methyl 
esters quantification was performed by using a Varian 430-GC equipped with a flame 
ionization detector and a CP-Select CB capillary column for fatty acid methyl esters 
(100 m* 0.25 mm i.d.; 0.25 mm i.d; 0.25 µm film thickness; Chrompack, Varian, Inc., 
Palo Alto, CA, USA). GC oven parameters, gas variables and peak identification were 
as previously described (Cicognini et al., 2013). Since a peak overlapping was found 
for C 19:0 (IS), the area of interfering peak was measured running each sample twice, 
with and without IS. This area was then subtracted from C 19:0 area to calculate the 
c9,t11 and t10,c12 CLA contents (expressed in mg/g of fat) in the meat samples. In our 
study, the co-elution of the c9,t11+t7,c9+t8,c10 triplet (Blasko et al., 2009) was not 
checked owing to commercial unavailability of the t7,c9 and t8,c10 isomer standards. 
Nevertheless, these isomers occur in very low amounts in ruminant fat (Kraft et al., 
2003). Thus, in this work the hypothetical c9,t11+t7,c9+t8,c10 peak was easily 
defined as c9,t11 CLA peak. 
 
Statistical analysis 
Data were tested for normality with the Shapiro-Wilk test. Non-normal variables 
were log-normal transformed before statistical analysis (Petrie and Watson, 2006). 
Data of FS study were analyzed by using two way analysis of variance (ANOVA) by 
GLM procedure of SAS (2010) and fixed effects of the model were sex (i.e., male vs. 
female), origin (i.e., Ireland vs. France-Italy vs. Piedmont) and their first order 
interaction. Data of SS survey were analyzed by using one way analysis of variance 
(ANOVA) by GLM procedure of SAS (2010) and fixed effect of the model was meat 
types (n=8). The significance level was set at P<0.05. 
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Results and Discussion  
FS study 
Recently, the main LRT located on Italy provide a commercial meat differentiation 
based on origin of carcasses. In particular, the main product typologies could be 
grouped as follows: Irish, French-Italian and Piedmontese meats. Piedmontese is the 
most important Italian autochthonous beef breed contributing for 37% to the beef 
production and for approximately 50% to the gross saleable product in Piedmont 
(Associazione Nazionale Allevatori dei Bovini di Razza Piemontese, 2011; 
Brugiapaglia et al., 2013). The Irish meat refers to meat obtained from animals either 
born or produced in Ireland, whereas the French-Italian to meat obtained from animals 
born and grown for a period in France, and then grown-finished and slaughtered in 
Italy. The other beef meats could be considered of less importance because of their 
lower market share and then were not considered in our current study (Rama et al., 
2013). The animal sex is another information provided by labelling for loin cut which 
is one of the meat cuts with higher share. Based on this differentiation, this study had 
the object to verify differences in c9,t11 and t10,c12 CLA contents of beef loin meats 
from animal of different origin and sex.  
Table 1 shows the c9,t11 and t10,c12 CLA contents and chemical composition of 
analysed beef loin meats. No differences were found in the c9,t11 and t10,c12 CLA 
contents of loin meat from male and female animals. Instead, both fat, moisture and 
protein contents differed (P<0.05). Female loin meat was 58% richer (P<0.05) in fat 
than male loin meat, therefore a portion of female loin meat might contain twice as 
much the c9,t11 CLA content than the same portion of male loin meat.  
Loin meats from Ireland, France-Italy and Piedmont showed differences in chemical 
composition. In particular, Piedmontese meat showed lower (P<0.05) content of 
intramuscular fat (-68% on average) compared with Irish and French-Italian meats. 
The Piedmontese breed is characterized by muscle hypertrophy or double-muscled. In 
agreement with our result, this characteristic was associated with meat with lower fat 
content than meat from normal animals (Aldai et al., 2006). Piedmontese meat 
exhibited also lower (P<0.05) c9,t11 CLA level (-35% on average) than Irish and 
French-Italian ones. Differences in fat content and a possible lower activity of ∆9 
desaturase enzyme in leaner animals, as reported by Siebert et al. (2003), Aldai et al. 
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(2006) and Brugiapaglia et al. (2013), could explain the lower c9,t11 CLA content in 
leaner animals compared with fatter animals. Moreover, a high positive correlation 
between c9,t11 CLA and intramuscular fat content was reported by Brugiapaglia et al. 
(2013). No difference was instead found in t10,c12 CLA content among the 
Piedmontese, Irish and French-Italian meats. On the other hand, the ruminal 
biohydrogenation is the only synthesis pathway responsible for the t10,c12 CLA level 
in ruminant products as animal tissues do not possess the desaturase enzyme capable of 
inserting a C 12-double bond into the t10 C18:1 molecule (Raes et al., 2004). 
 
SS survey  
To our knowledge, little information (Mele et al., 2008; Serra et al., 2009; 
Brugiapaglia et al., 2012) are currently available to estimate the consumption of c9,t11 
and t10,c12 CLA from meat in Italian consumers. The aim of current survey was to 
provide c9,t11 and t10,c12 CLA values of the main meat typologies commercialized in 
Italy and, on the basis of other works conducted by this research group on other foods, 
to estimate the daily c9,t11 and t10,c12 CLA intake in Italy.  
Table 2 shows the c9,t11 and t10,c12 CLA contents and chemical composition of 
meats from different animal species. Lamb meat had the highest (P<0.05) c9,t11 CLA 
content. In agreement, a review of Schmid et al. (2006) reported that c9,t11 CLA 
content in lamb meat could range from 4.3 to 19.0 mg/g fat. High c9,t11 CLA content 
of lamb meat could be associated with diet, being lamb fed with sheep milk that is 
recognized as the richest milk in CLA of all species (Jahreis et al. 1999). With values 
numerically higher than 11%, lamb and belly beef showed high fat contents. In 
agreement with our results, higher intramuscular fat levels were associated with higher 
c9,t11 CLA contents, being this CLA isomer predominantly deposited in the 
triacylglycerols (Lorenz et al. 2002; Raes et al., 2004). The c9,t11 CLA was lower 
than 2 mg/g fat in veal, pork and horse meats. Veal is cow’s milk fed. Thus, c9,t11 
CLA amount in veal tissues derives essentially from the animal diet being cow’s milk 
poor in polyunsaturated fatty acids precursors of the c9,t11 CLA synthesis in the 
rumen. Being non-ruminant animals, pork and horse meats showed c9,t11 CLA levels 
lower than 1 mg/g, in agreement with previous studies (Chin et al., 1992; Dufey, 1999; 
Schmid et al., 2006). Studies carried out on mice have shown that CLA is synthetized 
endogenously from dietary trans-vaccenic acid (Santora et al., 2000; Banni et al., 
2001; Khanal and Dhiman, 2004). Synthesis of CLA from trans-vaccenic acid has been 
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shown to occur in humans too (Adolf et al., 2000). Moreover, Alonso et al. (2003) and 
Coakley et al. (2003) reported that several species of bacteria derived from the human 
intestine can synthesize CLA. Canned beef meat showed a c9,t11 CLA content similar 
to that found in raw beef meat both from male and female animals.  
Low t10,c12 CLA amounts were found in all analyzed meat samples. On the other 
hand, as reported above, t10,c12 CLA is produced only by ruminal biohydrogenation 
(Raes et al., 2004). Beef female meat had the lowest (P<0.05) t10,c12 CLA level 
together with non-ruminant meats (pork and horse), whereas beef male and veal meats 
showed intermediate t10,c12 CLA values (P<0.05). Belly beef showed the highest 
(P<0.05) level of t10,c12 CLA. Since in belly beef most of fat is subcutaneous, the 
high t10,c12 CLA level found in this cut of beef meat might suggest that this CLA 
isomer is deposited mainly in subcutaneous fat, rather than in intramuscular fat.  
 
Conclusions 
This study is an integrative part of an extended work studying the CLA content in 
foods to estimate the daily CLA intake in an Italian cohort. In particular, it provided 
information on the c9,t11 and t10,c12 CLA contents in meats available from Italian 
LRT. Generally, meat contains low amounts of c9,t11 CLA and almost negligible 
levels of t10,c12 CLA for appreciation of health benefits in humans. Consequently, the 
consumption of other foods, such as milk and their by-products, should be encouraged 
to improve daily CLA intake by humans. Alternatively, specific feeding strategies 
should be taken in account in order to enhance the c9,t11 and t10,c12 CLA contents in 
meat.  
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Table 1.  Average c9,t11 and t10,c12 CLA contents (mg/g fat) and chemical composition (%) of beef 
loin meat from animals of different sex and origin. 
 
 
Sex1 Origin1 
 
 
 Male Female Ireland France-Italy Piedmont √MSE
3 
CLA c9,t11 2.98 2.88 3.34a 3.40a 2.19b 1.242 
CLA t10,c122 0.04 0.01 0.01 0.03 0.04 0.461 
Fat2 2.54b 5.98a 4.46a 6.70a 1.80b 0.687 
Moisture 74.21a 71.19b 72.26b 70.58b 75.00a 2.488 
Protein2 23.18a 22.03b 22.36 22.13 23.21 0.061 
 
1The interaction of sex and origin was not statistically significant; 2values were log-transformed before 
statistical analysis; 3root of mean-square error (MSE); a,bmeans in the same row within sex and origin 
with different superscripts differ (P<0.05).  
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Table 2.  Average c9,t11 and t10,c12 CLA contents (mg/g fat) and chemical composition (%) of meats from different animal species. 
 
 
All 
 
Beef male Beef female Veal Lamb Pork Horse Belly beef 
Canned  
beef meat √MSE2 
P  
of the model 
n
 
84 18 19 15 6 7 6 6 7 
c9,t11 CLA  2.98bc 2.88bc 1.28c 9.84a 0.67c 0.34c 4.24b 2.01bc 1.747 < 0.05 
t10,c12 CLA1  0.04b 0.01c 0.07b 0.02bc 0.01c 0.01c 0.36a 0.01c 0.822 < 0.05 
Fat1  2.54c 5.98bc 5.15bc 11.59ab 4.80bc 2.73c 19.81a 1.35c 0.810 < 0.05 
Moisture  74.21b 71.19b 73.11b 68.62b 70.80b 72.67b 55.35c 81.78a 3.761 < 0.05 
Protein1  23.18a 22.04ab 21.83ab 19.80b 22.73ab 23.00a 16.55c 13.63d 0.095 < 0.05 
 
n, number of samples; 1values were log-transformed before statistical analysis; 2root of mean-square error (MSE); a,b,c,dmeans in the same row with different superscripts 
differ (P<0.05) 
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Abstract  
During the last two decades, a lot of studies have been done to investigate the healthy 
properties of conjugated linoleic acid (CLA) isomers. However few works discussed 
the actual CLA intake in humans.  
To investigate the dietary behaviour of consumers, a three-days food questionnaire 
was administered to a cohort of 27 Italian students. Data from the food diaries were 
combined with a data-base on CLA content in foods. When a food was not included, 
Manuscript 4: Estimation of c9,t11 and t10,c12 conjugated linoleic acid isomers intake in a cohort of 
healthy students in Italy 
 
 90
a sample of it was analysed for its content in both cis9,trans11 and trans10,cis12 
CLA. 
CLA intake ranged from 8.7 mg/day to 545.4  mg/day and was higher in male than in 
female (164.70 mg/day vs 96.70  mg/day).  
The estimated CLA intakes in Italy were compared with data obtained in studies from 
other countries.  
 
 
Keywords:  CLA intake; food diary; CLA database; dairy products; meat products 
 
Abbreviations: CLA, conjugated linoleic acid; LA, linoleic acid; FAME, fatty acid 
methyl esters; t10,c12, trans10,cis12 CLA; c9,t11, cis9,trans11 CLA. 
 
1. Introduction  
 In the last two decades cis9,trans11 and trans10,cis12 conjugated linoleic acid 
isomers were recognised as healthy factors (Bhattacharya et al.1; Park et al.2; Raff  et 
al.3). CLAs are naturally present in ruminant food products as intermediates in the 
biohydrogenation of linoleic acid by rumen bacteria. c9,t11 isomer is also produced 
by vaccenic acid desaturation in the mammary gland (Bauman et al.4; Griinari and 
Bauman5), covering from 75 to 90% of total CLA in milk (Bauman et al.6). 
According to animal and cell culture experiments, c9,t11 plays a protective role 
against cancer and atherosclerosis (Bhattacharya et al.1) and can also attenuate insulin 
resistance (Taylor and Zahradka7; Hong et al.8). t10,c12  isomer can be instead 
related to the increase in energy expenditure and fat oxidation, to the decrease of 
adipocyte size and the inhibition of some enzymes involved in fatty acid metabolism 
and lipogenesis (Blankson et al.9; Bhattacharya et al.1). Due to these healthy 
properties, CLA content in food and the factors affecting CLA levels were also 
investigated. CLA content in milk and meat depends mainly on the feed regimen: as a 
matter of fact pasture was reported as a CLA enhancing factor, due to its high 
polyunsaturated fatty acid (PUFA) content, that are CLA precursors (Kelly et al.10; 
Collomb et al.11). Also species, breed, age and individual conditions could influence 
CLA content. As a matter of fact ewe milk is the richest in CLA among all milk types 
(Jahreis et al.12). Moreover CLA content in food can be affected by the food 
manufacturing: for example cooking temperatures, ripening period and microbial 
Manuscript 4: Estimation of c9,t11 and t10,c12 conjugated linoleic acid isomers intake in a cohort of 
healthy students in Italy 
 
 91
starter selection could influence the final CLA amount (Kim et al13, Sieber et al14). 
Several studies were performed to estimate the CLA daily intake in human subjects 
from different countries, and a strong variation in CLA intake among different 
countries was found. In Germany Fritsche and Steinhart15 using data from a national 
dietary survey estimated a daily CLA intake in man and women respectively of 440 
and 360 mg/d. In the same year Ritzenthaler et al.16 published US data from 3-days 
dietary records and calculated a CLA intake of 104 mg/d CLA for women and 176 
mg/d for men. The variation in daily intake among different countries may be due to 
dietary behavior and preferences, food processing, animal feeding. However also the 
method used to estimate the food intake could explain these discrepancies. 
Based on recent anticancer researches, Ip et al.17 proposed 3g/day as the lowest daily 
CLA intake to obtain anti-carcinogenic effects. Most of the studies on CLA intake 
however reported intake very far from this value. To our knowledge, no 
comprehensive information about CLA intake in Italy are nowadays available. 
Thus the main aim of our work was the estimation of the daily c9,t11 and t10,c12 
intake of young people in Italy. The data on CLA content in foods were reported in 
previous works (Prandini et al18,19, Cicognini et al20,21) and applied to a 3-days food 
diary record. 
 
2. Materials and methods 
2.1 Subjects and study design 
The present study was conducted according to the guidelines laid down in the 
Declaration of Helsinki, using the food record model. Written informed consent was 
obtained from all participants. 27 healthy subjects were recruited using 
advertisements posted on the university showcase. Subjects were selected basing on 
age, medical conditions and dietary behaviour. The selected age ranged from 19 to 25 
years old. Individuals with dyslipidemia, pregnant or breast-feeding and consuming 
an energy-restricted diet were excluded. Vegan or vegetarian people were not 
considered in this study. Subjects who satisfied inclusion criteria were then given 
instructions to write off a 3-days food diary previously validated and used in the 
Italian National Survey INRAN-SCAI (Leclercq et al.22) that was given them after 
they had signed the consent. They were asked to eat as usual in subsequent 3 days to 
emulate as best their habits. They were educated to indicate clearly each food they 
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introduced, when and where they ate it, and the number and quantity of serving 
portions. If they were not able to weight exactly each portion, a photographic atlas 
from EPIC study (Pisani et al.23) and Moli-Sani Project (Iacoviello et al.24) was used. 
In this atlas, plates, cup and spoons were illustrated in three portion sizes (small, 
medium and large): subjects had to choose the most similar image to their portion. At 
the end of the three days, food diaries were checked to study the daily CLAs intake. 
For each subject the mean daily intake of c9,t11 and t10,c12 were estimated by 
determining the content of these isomers in consumed foods over the weighted 
period. 
 
2.2 Database of CLA content of food 
Dairy products and meat products: data were obtained from our previous works 
(Prandini et al.18,19, and Cicognini et al.20,21). Grana Padano (GP) and Parmigiano 
Reggiano (PR) were discussed toghether. Subjects did not specify which type of 
Grana cheese was consumed, so an average of the CLA content of the two cheeses 
was used (6.0 mg c9,t11/g fat).  
Confectionary products were purchased in September 2012 in North-Italian large-
scale retail trade. They included the main commercial snacks available in Italian 
market. In table 1, 2 and 3 c9,t11 and t10,c12 amounts in foods were showed. 
 
2.3 Sample preparation 
Each hard and semi-hard sample was ground immediately after purchase with a 
mincing machine “La Moulinette 750 W”(Moulinex, France), while soft cheeses and 
cakes were gently hand pressed. The samples were then stored at -18°C and defrosted 
at room temperature before analysis. 
 
2.4 Reagents 
Chloroform, metanhol and sodium sulfate anhydrous were purchased from Carlo 
Erba Reagenti SpA (strada Rivoltana, Rodano, Milano, Italy). The standards c9,t11-
octadecadienoic acid and t10,c12-octadecadienoic acid were purchased by Matreya 
(Superchrom S.r.l., Milan, Italy); methyl-nonedecanoate (C19) standard was 
purchased by Sigma Inc. (Sigma-Aldrich Co, Milan, Italy). 
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2.5 Chemical analysis 
2.5.1 CLA quantification 
Lipid extraction was performed according to the modified Folch’s technique 
(Christie25): 10 g cheese or 30 g meat were mixed respectively with 100 or 300 ml 
chloroform–methanol mixture (2:1, v/v); after homogenizing in a Ultra-Turrax T25 
homogeniser (Janke & Kunkel, GmbH & Co, Staufen, Germany), the mixture was 
agitated for 60 min and was then filtered into a separator funnel through filter paper 
(Albet folded circles, 130 cm, extra rapid). Seventy-five ml of saturated NaCl 
solution were added to the filtrate; chloroform phase was subsequently recovered, 
dehydrated with anhydrous sodium sulfate (Na2SO4) and dried with a rotary 
evaporator at 40 °C under vacuum. 
Preparation of CLA isomers methyl esters: the esterification was in accordance with 
the method described by Bannon et al.26 with some differences. One hundred 
milligrams of extracted fat were weighed in a glass-stoppered test-tube of 
approximately 10 ml capacity and dissolved in 2 ml of hexane solution containing an 
internal standard (nonadecanoate methyl ester acid, 0.3 mg/ml). 2N methanolic-
potassium-hydroxide (100 µl) was added, the mixture was shaken vigorously for 30 s 
and allowed to react for a total of 6 min at room temperature (ca. 208°C). The 
catalyst (KOH) was neutralised immediately by adding 2N hydrochloric acid (100µl) 
with shaking, to the methyl orange end-point. The hexane phase, containing the CLA 
methyl esters (FAME), was separated by centrifugation and subjected to gas 
chromatography. 
Gas-chromatographic analysis: CLA methyl esters were quantified using a GC 
(Varian 430) equipped with a flame ionisation detector and a CP-Select CB capillary 
column for FAME (100 m* 0.25 mm i.d.; 0.25 mm i.d; 0.25 µm film thickness; 
Chrompack, Varian, Inc., CA). GC oven parameters and gas variables: isotherm 
analysis at 175°C for 65min, temperature of injection 250°C, detector temperature 
250°C, injection volume 1µl, gas carrier He and its flood 1.5 ml/min. CLA isomer 
peaks were identified by comparison with the retention times of reference standards 
adequately methylated (c9,t11 and t10,c12 octadecadienoic acid): C19:0 (IS) was 
eluted at 25.86 min, C18:2 c9,t11 at 33.72 min and C18:2 t10,c12 at 34.77 min. CLA 
content, expressed in mg/g fat, was determined by the following formula: 
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CLA(mg/g fat)=( area CLA*conc IS*CFCLA)/(areaIS*conc.fat*1.04) 
 
where ‘‘1.04’’ is the conversion factor from methyl ester to fatty acid and ‘‘CF’’ the 
isomer correction factor obtained from an average of 10 injections of a mixture 
containing 0.025g standard isomer (c9,t11 or t10,c12) adequately methylated and 
0.010 g nonadecanoate methyl ester. The CF correction factor was determined as 
follows: 
CFCLA=(area STD/area CLA)*(conc CLA/conc STD) 
 
2.5.2  Statistical analysis 
CLA content of foods 
All statiscal analysis were performed using the software SAS 9.2 (SAS Inst., Cary, 
NC, USA).  
Data were tested for normality using the Shapiro-Wilk test, non-normally distributed 
data were log-transformed and, if log-transformed data were normally distributed, 
means were compared (ANOVA) by PROC GLM of SAS 9.2. Data related to CLA 
t10, c12 were analyzed with a non-parametric test: Krauskal-Wallis (ANOVA). 
The least significant difference (LSD) was obtained by Tukey’s test and used for the 
multiple comparison between means.  
Significant level of difference was set al P<0.05.  
 
 
 
 
Estimation of CLA intake 
The comparison of means of CLA intake in males and females was carried out with 
the t Student test, while the multiple comparison between means was performed using 
the Bonferroni test. 
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3 Results and Discussion  
 
3.1 Anthropometric measurements of volunteers  
The mean BMI of female volunteers was 22.5 + 3.6, whit a body fat percentage of 
30.0 + 5.6 % while the BMI value for male was 22.5 + 1.7 and body fat percentage 
was 16.0 + 3.4 %.  
 
3.2 CLA content in dairy products 
CLA isomer amounts in dairy products were showed in Table 1. 
c9,t11 is predominant among the CLA isomers in dairy products, while t10,c12 is 
almost absent. 
As expected, ripened cheeses contained more c9,t11 than fresh cheeses (Fontina 8.1 
mg/g fat; Emmental 7.66 mg/g fat) (Prandini et al.18). These values are higher than 
c9,t11 content in mature Cheddar reported by Mushtaq et al.27 in UK and by Chin et 
al. in US (respectively 6.1 and 4.7 mg/g fat). The high level of CLA in these cheeses 
could be related to the ripening period as well as the pasture feeding: Kim et al.13 and 
Sieber et al.14 reported that a medium-long ripening period increased CLA amount in 
cheeses. Moreover Propionibacterium spp. starter (Disciplinare di produzione della 
DOP “Fontina”29) could have affected CLA amount in Fontina DOP. As a matter of 
fact Sieber et al.14 showed that CLA can be produced from linoleic acid through the 
action of Lactobacillus spp., Lactococcus spp. and Streptococcus spp., able to convert 
up to 10% of free linoleic acid in CLA, and of Propionibacteria spp. converting up to 
90% of linoleic acid. 
Butter content of c9,t11 was higher than the estimation of Mushtaq et al.27 (2.5 mg/g 
fat), Martins et al.30 (3.87 mg/g fat), Chin et al.31 and Ma et al.32 (4.7 mg/g fat), while 
it was lower than German butter (9.4 mg/g fat) (Fritsche and Steinhart15) 
Sliced processed cheese contained 6.37 mg c9,t11/g fat, less than 11.9 and 7.3 mg/g 
fat found respectively in German and UK processed cheese and more than 4.65 mg/g 
fat reported in US work. 
In dairy products t10,c12 CLA was almost absent. It was found only in traces in 
Philadelphia and Scamorza (respectively 0,15 and 0,16 mg/g fat). Martins et al.30 
reported instead lower but detectable values: 0.03 mg/g fat in butter and 0.0004 mg/g 
fat in cheeses. 
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3.3 CLA content in meat 
c9,t11 was the main CLA isomer also in meat products, while t10,c12 amount in meat 
was lower  probably because t10,c12 derive only from the rumen production, while 
tissues do not have the needed desaturase enzyme (Raes et al. 32). 
Lamb was found the c9,t11 richest meat (8,95 mg/g fat). This is in according with 
Martins et al.30, who reported a c9,t11 content of 8.73 mg/g fat. A similar amount 
(8.2 mg/g fat) was detected also in lamb from UK (Mushtaq et al.27). Fritshe and 
Steinhart15 reported instead a higher CLA concentration (12 mg/g fat). In the works 
of Haumann and Snell33, Ivan et al. 34 and Schmid et al.35 CLA values in lamb ranged 
from 2 to 19 mg/g fat. The high values of CLA in lamb were expected: as a matter of 
fact lamb is fed with ewe milk that is naturally rich in CLA. Beef (2,89 mg/g fat) 
followed lamb meat. Our c9,t11 value was in according with Martins et al.30 while 
was lower than the c9,t11 amount found in beef from UK, Germany and US 
(Mushtaq et al. 27; Fritshe and Steinhart15, Chin et al.28). 
In our work the most relevant amount of t10,c12  was found in calf meat as 0,07 mg/g 
fat, while beef contained 0,03 mg/g fat. Martins et al.30 and Mushtaq et al.27 instead 
reported higher amount in beef (respectively 0,11 and 0,07 mg/g fat). 
 
3.4 CLA content in confectionery 
Confectionery products included snacks from the most spread labels in Italy. 
Chocolate bars with or without cereals and sponge cake, wafer, brioches, puddings 
and ice creams were studied. CLA isomers content was showed in table 3. Chocolate 
pudding and cream caramel contained more c9,t11 than the other confectionaries, 
respectively 5,17 and 4,29 mg/g fat; brioches filled with cream followed (3,00 mg/g 
fat). The CLA content of these confectionery products is most likely to have been 
derived from the milk involved in their manufacture. 
 
 
3.5 Estimation of the mean daily CLA intake 
In our cohort the calculated average daily c9,t11 intake was 133,14 mg. A significant 
difference in CLA intake between male and female was found (Tab. 5). Males 
introduced daily 164,70 mg of c9,t11, while females introduced 96,90 mg/d. It has to 
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be considered that the CLA isomers intake is related to the total food intake, usually 
higher in males than females. Food consumption was affected by sex: males 
introduced significantly higher amounts of c9,t11 from cheese (115,70 mg/g fat) and 
ham (2,12 mg/g fat) than females (respectively 65,79 and 0,98 mg/g fat). CLA 
intakes from other foods were instead similar in the two sexes.  
Table 4 reports data on the contribution of different food groups on CLA intake. 
Cheeses accounted for more than 65% of CLA intake and can be recognised as the 
main sources of CLA for young people. Milk is the second food for contribution to 
CLA intake (15.39 %), while yoghurt, meat and confectionery showed a minor 
contribution (respectively 45,13 and 42,21 mg/day). 
 
CLA sources 
The percentages of CLA introduced with each food on total CLA intake were also 
showed. CLA intake from cheese was found the 61,96% of total CLA introduced. 
Milk percentage (13,20 %) was lower, but significantly higher than the other foods. 
Dairy foods were the main sources of CLA in the paper of Ritzenthaler et al.16 also. 
This data were in agreement with the paper of Jiang et al.36 who reported a significant 
positive relationship between milk fat intake and CLA content of adipose tissue. Also 
in the work of Voorips et al.37 the main sources of CLA were dairy foods, however in 
this paper, butter accounted for almost the 30% of CLA intake, while in our 
experiment butter was poorly consumed by our volunteers. 
 
CLA intake 
Values from several countries were showed in table 6. Our results were in accordance 
with Mushtak et al.27 and Ens et al.38, who found a mean daily CLA intake 
respectively of 97,5 and 94,9 mg. Both the works used a dietary record in a small 
cohort. Martins et al.30 and Fritshe and Steinhart11 used instead national dietary 
survey data: the first work reported a CLA daily intake lowers than ours, while the 
second one showed higher intakes (400 mg/d). Parodi et al.39 indicated a very high 
CLA intake in Australia ranging from 500 to 1500 mg/day and evaluated individual’s 
dietary preferences and seasonal factors affecting CLA in milk and ruminant fat. 
Ritzenhaler et al.16 estimated a CLA intake ranging from 104 for females to 176 
mg/day for males in USA population, values very close to our results. 
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These data suggest that CLA intake is very far from recommended daily intake 
proposed by Ip et al.17 , however this gap is probably lower than expected because it 
has to be considered that 20% of the dietary vaccenic acid is converted endogenously 
to CLA in human subjects (Turpeinen et al.40). Dairy products contain about twofold 
vaccenic acid than CLA, thus the conversion factor to the real CLA intake can be 
calculated as 1,4.  
Other factors explaining the difference in CLA intake between different Countries are 
related to factors affecting CLA levels in food, e.g. animal feeding (grazing increase 
CLA levels in milk and meat), animal species (milk and meat from sheep are richest 
in CLA than similar products obtained from bovine or goats).  
The methods used for estimating food consumption and CLA intake, can also affect 
the results. National dietary analyse data from cohort bigger than ones used when 
food frequency questionnaires are used, these different approach could affect the 
estimation of CLA intake.  
 
3.4.1 Comparison between male and female CLA intake 
The differences in CLA intake between males and females are shown in Tab. 2. 
Male subjects in our study daily introduced a CLA amount of 164,70 mg, while 
females reached an intake of 96,90 mg. A US study on 3-days women dietary record 
made by Ritzenthaler et al.16 reported a lower daily CLA intake of 50 mg/d. Fritshe 
and Steinhart15 described instead a daily men and woman intake respectively of 440 
and 360 mg, an higher amount than our results. Mushtaq et al.27 reported a CLA 
intake lower than ours, either in male (126.7 mg/d) and female (68.3 mg/d).  
In our experiment a significant difference was found in the CLA intake from cheese 
and ham: males introduced more CLA with these products (115,7 and 2,12 mg/d 
respectively from cheese and ham) than females (65,79 and 0,97 mg/d). 
 
3. Conclusions 
Data obtained in the present study show that CLA intake in a cohort of University 
Italian students is lower than value proposed by Ip et al17 as biologically relevant. 
Within the cohort, male subjects introduced more CLA than females one. Dairy foods 
were the most relevant sources of CLA in both sexes. These data confirm that in 
order to improve CLA intake, the main focus should be on dairy foods whose CLA 
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content can be increase by means of microbial starter with CLA producing bacteria or 
a more widespread use of grazing for lactating animals. 
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Table 1.  Average CLA isomers content in dairy products. 
 
Dairy products 
 c9,t11 CLA 
 
t10,c12 CLA 
Reference 
 mg/g fat 
 
mg/100g prod. 
 
mg/g fat 
 
mg/100g prod. 
          Butter  6.71  564.24  n.d.  - Prandini et al. 2001 
Yoghurt  4.45*(4.00)    n.d.  - Prandini et al. 2007 
Grana  6.00*(5.40)    n.d.  - Prandini et al. 2009 
Mozzarella  6.26  99.66  n.d.  - Cicognini et al., unpublished data 
Ricotta  5.18  55.27  n.d. 
 
 - Cicognini et al. 
Scamorza  4.62  96.23  0.16  3.33 Cicognini et al. 
Sottiletta  6.37    n.d.  - Cicognini et al., unpublished data 
Fontina  8.11*(7.30)    n.d.  - Prandini et al. 2007 
Crescenza  4.20  91.01  n.d.  - Cicognini et al. 
Philadelphia  5.20  115.91  0.15  3.34 Cicognini et al. 
Zola  5.16*(4.64)  148.30   n.d.  - Prandini et al. 2011 
Emmental  7.66*(6.89)     n.d.  - Prandini et al. 2007 
Caciocavallo  5.24  154.58  n.d.  - Cicognini et al. 
Caciotta  5.55  158.62  n.d.  - Cicognini et al. 
 
* c9,t11 values are adjusted as 90% of total CLA reported by these authors. 
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Table 2.  Average CLA isomers content (mg/g fat) in meat products (Cicognini et al.) 
 
Meat 
c9,t11 CLA  t10,c12 CLA 
mg/g fat  mg/100g prod.  mg/g fat  mg/100g prod. 
Beef  2.87   12.22  0.03  0.13 
Calf 1.28  6.59  0.07  0.36 
Lamb 8.95  103.73  0.03  0.35 
Pork 0.68  3.26  0.02  0.10 
Horse 0.35  0.96  0.01  0.03 
Canned meat 1.99  2.63  0.01  0.01 
Raw ham 0.62  10.25  n.d.  - 
Cooked Ham 0.52  3.70  n.d.  - 
Bresaola 0.64  1.21  n.d.  - 
Pancetta 0.60  27  n.d.  - 
Mortadella 0.58  14.73  n.d.  - 
Salame 0.51  14.54  n.d.  - 
Speck 0.57  8.16  n.d.  - 
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Table 3.  Average CLA isomers content (mg/g fat) in sweets. 
 
Confectionary 
 
c9,t11 CLA 
 
t10,c12 CLA 
 
   
 mg/g fat  mg/100g prod. 
 
mg/g fat 
Milk chocolate bar with cream and wafer  0.02     n.d. 
Milk chocolate bar 1  1.18     n.d. 
Milk chocolate bar 2 
 
 1.18     n.d. 
Milk chocolate tab with cereals  0.99     n.d. 
Sponge cake covered and filled with milk 
chocolate 
 1.18     n.d. 
Wafer  n.d.     n.d. 
Chocolate brioche  n.d.     n.d. 
Plum Cake  0.17     n.d. 
Chocolate sponge cake  0.06     n.d. 
Cream brioches   3.00     n.d. 
Vanilla pudding  4.29     n.d. 
Chocolate pudding   5.17     n.d. 
Cream caramel  5.17     n.d. 
Ice cream  n.d.     n.d. 
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Table 4. Average of c9,t11 daily intake (mg) and of c9,t11 % (on total c9,t11) introduced with each food in a cohort of 40 students.  
 
 
Means in the same column with different superscripts differ (P<0.05).  
CLAA = CLA intake (mg/day) from each food; 
CLA %B = % CLA introduced with each food calculated on total CLA intake (3days); 
√MSEC= root mean square error 
 
 
 
 
 
Food 
 
CLAA  CLA %B  
Cheese  85.76a  61.96a  
Milk  15.39b  13.20b  
Yoghurt  7.81b  7.51c  
Confectionery  4.71b  3.17c  
Meat  4.39b  3.46c  
Ham  1.43b  1.16c  
Olive oil  4.54b  3.61c  
√MSEC  91.42  13.99  
P  <0.0001  <0.0001  
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Table 5. Average of daily c9,t11 intake and of c9,t11 % (on total c9,t11) introduced with each food in male (n=16) and female (n=24) subjects; 
Average of the total c9,t11 intake of male and female in 1 and 3 days.  
             
Food  CLAA  CLA %B  
             
             
  M F  √MSEC P  M F  √MSEC P 
             
             
             
Cheese  115.70a 65.79b  228.80 <0.05  66.13 59.19  28.37 n.s. 
Milk  20.57 11.93  47.19 n.s.  16.83 10.78  14.75 n.s. 
Yoghurt  9.97 6.37  30.39 n.s.  8.56 5.94  14.62 n.s. 
Confectionery  7.33 2.96  33.48 n.s.  3.73 2.79  7.57 n.s. 
Meat  7.35 2.42  26.42 n.s.  5.26 2.26  5.58 n.s. 
Olive oil  1.66 6.45  31.75 n.s.  1.85 4.78  6.65 n.s. 
Ham  2.12a 0.98b  4.97 <0.05  1.63 0.84  1.39 n.s. 
             
 
CLA1dD   164.70a 96.90b  89.94        <0.05       
CLA3dE  494.12a 290.70b  269.82        <0.05       
             
             
Means in the same row with different superscripts differ (P<0.05).  
CLAA = CLA intake (mg/day) from each food; 
CLA %B = % CLA introduced with each food calculated on total CLA intake; 
MSEC= root mean square error 
CLA1dD= Average of total CLA intake (mg) in 1 day 
CLA3dE =Average of total CLA intake (mg) in 3 days 
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Table 6. Average CLA intake (mg/d) estimated in studies from several countries. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Year  Country  
Daily 
intake 
 
Estimated 
isomer 
 Method  Authors 
                         2010  UK  97.5  c9,t11  3d dietary record  Mushtak et al.30 
 2001  Canada  94.9  c9,t11  7d dietary record  Ens et al.31 
 2007  Portugal  73.7  c9,t11  National dietary survey  Martins et al.32 
 1998  Germany  400  c9,t11  7d dietary record  Fritshe &Steinhart 11 
 1994  Australia  500-1500  Total CLA  -  Parodi et al.33 
 2001  USA  79-133  c9,t11  3d dietary record  Rizenthaler et al.12 
 2002  UE  250  c9,t11  milk intake  Wolff & Pricht 
 1999  Sweden  350-430  c9,t11  1d dietary record  Jiang et al. (1999) 
 1998  USA  127  c9,t11  3d dietary record  Herbel et al. (1998) 
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         Abstract  
The aim of the work was to investigate the effects of breed (Aberdeen Angus (AA) and 
Belgian Blue (BB)) and diet promoting conjugated linoleic acid (CLA) synthesis or 
supplementing n-3 PUFA) (ω3) on the expression of genes related to lipid and CLA 
metabolism. The genes investigated can be divided into those encoding: 1) lipogenic 
enzymes such as ACC, FAS, SCD, ∆6D, ∆5D and ELOVL5; 2) factors involved in lipid 
metabolism such as AMPKα, ADIPOQ and GPR43; 3) transcription factors including 
SREBP1c, PPAR γ and α and STAT5; 4) lipid storage-associated proteins such as 
ADFP; and 5) energy metabolism such as GLUT4. 
AA and BB breeds were chosen due to their different rates of maturity. 
ACC and SCD gene expression were higher in BB (P=0,013; P= 0,055), while FAS 
expression was higher in AA (P=0,007). 
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 FAS and SCD expressions were increased by n-3 FA supplementation (P=0,006; 
P=0,074). 
Finally an interaction between breed and dietary n-3:n-6 ratio was observed for PPARα 
(P= 0,006) and ADIPOQ (P=0,055). Thus, PPARα expression was reduced by n-3 FA 
in AA and increased in BB; ADIPOQ was found higher in AA and lower in BB with 
CLA.  
Thus breed and diet could affect the gene expression of CLA-related genes, however 
more studies are needed to describe the underlying mechanisms.  
 
Keywords: gene expression, CLA, diet, SCD, PPARs, n-3 PUFA, n-6 PUFA  
 
Abbreviations: fatty acid (FA); saturated fatty acid (SFA); polyunsaturated fatty acid 
(PUFA); α-linolenic acid (ALA); linoleic acid (LNA); eicosapentaenoic acid (EPA); 
docosahexaenoic acid (DHA); conjugated linoleic acid (CLA); acetyl-CoA carboxylase 
(ACC); fatty acid synthase (FAS); stearoyl-CoA desaturase (SCD); delta-6-desaturase 
(∆6D); delta-5-desaturase (∆5D); fatty acid elongase 5 (ELOVL5); activated protein 
kinase (AMPKα); adiponectin (ADIPOQ); G protein-coupled receptor (GPR43); sterol 
regulatory element-binding protein1c (SREBP1c); peroxisome proliferator-activated 
receptor γ and α (PPARγ; PPARα); statin (STAT5); adipose differentiation-related 
protein (ADFP); glucose transporter 4 (GLUT4); Aberdeen Angus (AA); Belgian Blue 
(BB). 
 
1. Introduction 
In the last decade many studies have been conducted in order to improve its fatty acid 
(FA) composition. In fact, meat was considered as a source of saturated fatty acids 
(SFA) that could be implicated in some cancers and in coronary heart disease (1). 
However beef also provides polyunsaturated FA, that can be distinguished mainly into 
n-3 PUFA, produced from α-linolenic acid (ALA, C18:3), and n-6 PUFA, produced 
from linoleic acid (LNA, C18:2) (Williams, 2000). Among n-3 PUFA, 
eicosapentaenoic acid (EPA, C20:5) and docosahexaenoic acid (DHA, C22:6) are 
recommended by the American Heart Association for reducing the risk for coronary 
heart disease (CHD) (3,4).  
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The ratio n-6:n-3 PUFA was reported as an important risk marker for cancers and 
coronary heart disease (5) 
n-6 PUFA include the isomers of conjugated linoleic acid (CLA), where cis9,trans11 
and trans10,cis12 CLA are the most important: c9,t11 CLA is believed to have anti-
carcinogenic and anti-atherosclerotic properties and to reduce insulin-resistance (6,7) 
while t10,c12 is mainly related to a decrease of fat mass (8). 
Animal breed, sex, age and diet are the main factors affecting FA composition of meat 
(9). French et al. (10) showed that pasture enhanced CLA concentration, increased the 
ratio of PUFA:SFA and improved the n-6:n-3 PUFA ratio, if compared with grass 
silage and concentrate feeding. Moreover the improvement was  related to the duration 
of grazing (11). Also oil supplementation affects the fatty acids profile of beef: fish oil 
supplementation enriched n-3 PUFA (3) while sunflower oil enhanced the amount of 
CLA in meat (12). However it was also reported that an accumulation of vaccenic acid 
as CLA precursor in tissues did not increase CLA (4), thus suggesting the involvement 
of other mechanisms. The alteration of lipogenic gene expression due to diet could be 
the limiting step, modifying related protein expression or enzyme activities 
(13,14,15,16). For example dietary CLA was reported to affect the expression of some 
of the most important genes implicated in the lipid metabolism (17,18); Waters et al. 
(15) showed that dietary n-3 PUFA inhibits the genes encoding for CLA synthesis; 
Hiller et al. (19) reported a beneficial decrease of n-6:n-3 PUFA ratio due to the 
reduction of ACC, FASN and ∆6D gene expression. 
Thus there is a rising interest in elucidating the factors affecting the n-6 vs. n-3 PUFA 
balance together with increasing CLA concentration in meat, as CLA improves it’s 
nutritional value due to the related healthy properties. Moreover a CLA intake of 
3g/day should be reached, obtaining the minimum value needed for positive health 
effects from the exptrapolation af animal diet fro humans (20). In addition more recent 
studies showed that an intake of 0.8-3 g/day could be sufficient to exert the CLA 
effects (21) 
This work aimed to investigate the influence of breed and of the n-3 vs. n-6 PUFA 
ratio in the diet on the expression of genes involved in CLA synthesis or affected by 
CLA in beef cattle. The complex pathways involving these genes are summarized in 
Figure 1. 
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Some of the genes studied are directly involved in  fatty acid synthesis, such as acetyl-
CoA carboxylase (ACC), fatty acid synthase (FAS), stearoyl-CoA desaturase (SCD), 
delta-6-desaturase (∆6D), delta-5-desaturase (∆5D) and fatty acid elongase 5 
(ELOVL5). Other targeted genes  are affected by CLA and can be related to lipid 
metabolism: activated protein kinase (AMPKα), adiponectin (ADIPOQ), sterol 
regulatory element-binding protein 1c (SREBP-1c), G protein-coupled receptor 
(GPR43), peroxisome proliferator-activated receptor γ and α (PPARγ, PPARα), statin 
(STAT5), adipose differentiation-related protein (ADFP), glucose transporter 4 
(GLUT4).  
 In this context n-6 (sufflower oil) vs. n-3 (protected fish oil) PUFA effects on 
lipogenic gene expression were studied in bovine longissimus dorsi muscle of 
Aberdeen Angus and Belgian Blue breeds. These breeds were chosen due to 
contrasting attributes in terms of maturity (AA is an early maturing breed, while BB is 
late maturing breed)  
 
2. Material and Methods 
Animals, study design and tissue sampling 
Spring-born early-maturing Aberdeen Angus × Friesian heifers (AAF, n=24) and late-
maturing Belgian Blue × Friesian heifers (BBF, n=24) were reared from four months 
of age according to the heifer grass-based dairy calf to beef blueprint described by 
Keane and Drennan (22). Within breed, the animals were blocked on bodyweight and 
within block assigned at random to the control system (CON) or to continued 
supplementation with a safflower oil-containing supplement (SAFF) or protected 
fishoil-containing supplement (PFO). Thus, CON animals grazed a perennial ryegrass-
dominant sward from July 1, and were offered a daily allowance of grass dry matter 
(DM) sufficient to ensure a consumption of 2.5% bodyweight (assuming 75% 
utilisation) for the whole group.  They were housed November 30 and offered unwilted 
grass silage ad libitum and 1.0 kg standard concentrates per animal daily until turnout 
to pasture on April 1. Thereafter until slaughter at the end of October, they again 
grazed a perennial ryegrass-dominant sward. Housing and turnout dates were the same 
for SAFF and PFO animals as for CON animals. However, in each case, the animals 
received a supplement formulated to supply 50g lipid / kg total dietary DM (Table 1). 
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At pasture, the SAFF animals received a supplement allowance of 2.5 kg/425 kg 
bodyweight, while the PFO animals received an allowance of 1.82 kg/425 kg 
bodyweight. For both SAFF and PFO groups, the animals received a restricted daily 
grass allowance to ensure similar carcass growth as the CON group. Upon housing, 
SAFF animals received a restricted amount of wilted silage + 2.5 kg supplement/425 
kg bodyweight while PFO animals received a restricted amount of unwilted silage + 
1.82 kg supplement/425 kg bodyweight. These ration allowances were adjusted to 
ensure similar mean liveweight growth as the CON animals. Upon turnout, animals in 
the SAFF and PFO groups were managed as described for the previous summer. 
At 21 months of age, animals were slaughtered and longissimus dorsi (LD) muscle was 
collected as decribed by Keady et al. (11)  
 
 
RNA Extraction, cDNA Synthesis, and Real-Time Quantitative PCR 
Total RNA was isolated from frozen muscle tissue using TRI reagent (Sigma-Aldrich 
Ireland Ltd., Dublin, Ireland) and immediately precipitated using isopropanol. The 
samples were then purified using the Zymo RNA purification Kit (Zymo Reasearch 
Corporation. The quantity and purity of RNA were measured using absorbance at 260 
nm on a spectrophotometer (NanoDrop Technologies, Wilmington, DE). All RNA 
samples had a 260:280 nm absorbance ratio between 2,04 and 2,14.  
The Agilent Bioanalyser with the RNA 6000 Nano LabChip kit (Agilent Technologies 
Ireland Ltd., Dublin, Ireland) was used to assess the 28S:18S ratio and the RNA 
integrity number (RIN) by automated capillary gel electrophoresis. One microgram of 
total RNA was reverse transcribed to cDNA, with random hexamers, using the High 
Capacity cDNA Reverse Transcription kit (Applied Bio- systems, Warrington, UK), 
according to instructions supplied, and stored at −80°C. 
Real-time quantitative PCR (RT-qPCR) was used to measure gene expression. 
Primers were designed to amplify templates of a specific range between 70 and 200 
nucleotides overlapping exon-exon junctions where possible, using the primer3 web-
based software program (http://frodo.wi.mit.edu/primer3), while the primer specificity 
was checked using the BLAST search tool (http://www.ncbi.nlm.nih.gov/BLAST/). 
The sequences of primers used for each gene were commercially synthesized (Sigma-
Aldrich Ireland Ltd.). 
 In Table 1 the designed primer specifications for each gene are reported. 
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The stability of expression of candidate reference genes was investigated across all 
samples in the study. Reference genes included β-actin (ACTB), ribosomal protein S18 
(RPS18), glyceraldeyde-3-phosphate dehydrogenase (GAPDH), ubiquitin conjugate 
protein (UBIQ) and B2 microglobulin (B2M).  The resulting expression data were 
analyzed using geNorm software (version 3.5, Excel add-in, Microsoft, Redmond, 
WA) as described by Vandesompele et al. (23) to test the overall stability of the chosen 
reference genes. The expression stability value was estimated (M) for each reference 
gene (the lowest M value being the most stable) using this program. The reference 
genes with the highest M values were excluded and geNorm determined the minimal 
number of reference genes required for calculating an accurate normalization factor. In 
the current study, the highest stability was obtained including 4 reference genes, 
ACTB, RPS18, GAPDH and UBIQ achieving a M value < 1.5. 
All RT-qPCR reactions were performed using SYBR Fast Green mastermix (Applied 
Biosystems). Assays were carried out under identical conditions, and all samples were 
measured in triplicate using the Applied Biosystems Fast 7500 v2.0.1 instrument with 
the following cycle parameters (95°C for 15 s, 60°C for 60 s, 95°C for 15 s, and 60°C 
for 15 s). Primer and cDNA concentrations were optimized for each gene. The 
efficiency of the reaction was calculated using a 5-fold dilution series of cDNA to 
generate a standard curve. All PCR efficiency coefficients ranged between 0.8 and 
1.20, therefore acceptable. The software package GenEx 5.2.1.3 (MultiD Analyses AB, 
Gothenburg, Sweden) was used for efficiency correction of the raw cycle threshold 
values, interplate calibration based on a calibrator sample included on all plates, 
averaging of replicates, normalization to the reference gene, and the calculation of 
quantities relative to the highest cycle threshold value. 
 
Statistical analysis 
Data collected from the experimental trial were checked for normality using the 
UNIVARIATE procedure of SAS (SAS Inst. Inc., Cary, NC). Where necessary, data 
were transformed using the TransReg procedure, by raising to the power of λ. Data 
were then subjected to Analysis of Variance for a split-plot design with block and 
breed (B) in the main plot and ration (R) and all interactions in the split-plot. 
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3. Results  
The expression of 15 candidate genes was analysed in this study. These genes are 
involved in the pathways summarized in Figure 1.The genes can be divided into those 
encoding: 1) lipogenic enzymes such as ACC, FAS, SCD, ∆6D, ∆5D and ELOVL5; 2) 
factors involved in lipid metabolism such as AMPKα, ADIPOQ and GPR43; 3) 
transcription factors including SREBP1c, PPAR γ and α and STAT5; 4) lipid storage-
associated proteins such as ADFP; and 5) energy metabolism such as GLUT4. 
Table 3 summarises the effects of breed and dietary n-6 and n-3 PUFA ratio on the 
expression of candidate genes.  
 
Effect of breed on gene expression 
The expression of the gene encoding ACC was  higher (p=0.013) in BB than in AA. In 
addition, FAS gene expression was  higher (p=0.007) in AA than in BB. 
 (p=0.055) for SCD expression tended to be higher for BB than in the AA breed.  
No effect of  breed was found in the expression levels of the other genes examined. 
 
Effect of oil supplementation 
The expression of the gene encoding for FAS was  increased (p=0.006) by 
supplementation with n-3 PUFA compared with both the control and the SAFF 
supplementation group. SCD gene expression showed a tendency (p=0.074) for the 
same effect, although this increase was not statistically significant. 
Regarding the other genes encoding for lipogenic enzymes, an absence of significant 
relationships among n-3:n-6 PUFA ratio and ∆5D, ∆6D gene expression was showed, 
while a trend could be found between the n-3:n-6 PUFA ratio and ELOVL5 (P= 0.198) 
and GPR43 (P=0.199): gene expression. CLA supplementation resulted in both genes 
having higher expression among the n-3:n-6 ratios, with lower expression of these 
genes observed due to n-3 supplementation. 
No effect of n-3:n-6 ratio was observed on the expression of the other genes analysed. 
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Breed X Oil supplementation 
An interaction between breed and dietary n-3:n-6 ratio was observed for the PPARα 
gene:  ω3 supplementation significantly reduced PPARα expression in AA, while it 
was increased in BB (P= 0.008). 
 SAFF supplementation  increased the expression of ADIPOQ in AA but  decreased it 
in BB (P=0.055). 
 
4. Discussion 
 
The effect of breed and dietary fatty acid intervention on shifts in the expression of 
genes related to CLA and lipid metabolism was examined in this study. The gene 
studied are categorised as follows: 1) lipogenic enzymes such as ACC, FAS, SCD, 
∆6D, ∆5D and ELOVL5; 2) factors involved in lipid metabolism such as AMPKα, 
ADIPOQ and GPR43; 3) transcription factors including SREBP1c, PPARγ and α and 
STAT5; 4) lipid storage-associated proteins such as ADFP; and those involved in 5) 
glucose metabolism such as GLUT4. 
 
Effect of breed on gene expression 
ACC and SCD gene expression were higher in BB, in contrast with the expectation that 
early maturing breeds should show higher gene expression than late maturing cattle. In 
fact AA was expected to have higher levels of gene expression  than BB, which is late 
maturing. Moreover the expression of genes involved in fatty acid synthesis was 
expected to be higher in AA also due to the higher fat content associated with this 
breed. For example, Barton et al., (24) reported the highest levels of expression of 
ACC, FAS and SCD1 in intramuscular fat of AA and Holstein bulls when compared 
with other breeds and justified the results due to these breeds having increased fat 
depots.  
It could be hypothesized that our results in the AA breed component of the crossbred 
animals used in the study. Moreover the literature reports that high intramuscular fat in 
Angus is positively related to higher ACC and FAS genes expression (24). Thus the 
quantity of fat might be another factor explaining the lower gene expression in AA 
crossbreed than BB crossbreed in our study. 
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In addition, Smith et al (25) reported that acetate incorporation into fatty acids in 
adipose tissue of Angus × Hereford and Red Poll steers increased between 10 and 16 
mo of age and decreased with additional time on hay feed, and the same was found for 
ACC and FAS lipogenic enzyme activities. Thus the age of our animals (>16 months) 
and the long-fed could suggest that the sampling was done during the stage of 
decreasing SCD gene expression and therefore reduced lipogenesis for an early 
maturing breed such as AA compared to BB. 
Also Chung et al. (26) showed a depressed rate in lipogenesis in long-term fed steers 
and concluded that the increase in SCD gene expression probably resulted in a 
proportional increase in lipogenesis only in the first period of feeding. 
Moreover BB is characterized by muscular hypertrophy, which occurs because of 
mutations in the myostatin coding sequence as reported by McPherron, (27). The 
consequence of this, as explained by Keady et al., (11) is the higher glycogen 
metabolism in the muscle of BB breed. Thus, in a muscle where Acetyl-CoA is basic, 
if it is supposed to be a limiting substrate, the muscle could show higher ACC gene 
expression in the BB breed. 
In contrast, FAS expression was higher in the AA breed. That may be due to the early 
maturity of this breed as reported above, to its pattern of fat storage. Moreover this 
result could also be related to the available concentration of Malonyl-CoA, which is a 
substrate for the FAS enzyme: It could be hypothesized that in an early maturing 
breed, the concentration of this substrate were higher than in the late maturing breed 
BB. 
 
Effect of oil supplementation 
Regarding the genes in group 1), an increase in FAS gene expression and an increasing 
trend in SCD due to n-3 PUFA supplementation were observed. No differences due to 
dietary treatment were found in ACC, ∆5D, ∆6D expression.  
Our findings agree with work of Buchanan et al. (28) who reported an up-regulation of 
FAS gene expression in forage-finished heifers, and with those of Hiller et al. (19,29).  
Regarding SCD gene expression, our findings were in contrast with Hiller et al. (19,29) 
and Waters et al., (15), who reported a significant decrease in SCD gene expression 
upon dietary n-3 fatty acid intervention. Also the work of Conte et al. (30) showed a 
decrease in SCD mRNA abundance after the replacement of sunflower oil (n-6 PUFA) 
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with linseed oil (n-3 PUFA) in lambs. Consistent with these findings, Buchanan et al 
(28) observed an up-regulation of SCD gene in animals fed with concentrates and a 
down-regulation after forage feeding. 
However, gene expression can vary due to FA intervention in the diet, depending on 
tissue, breed and sex (29). The works of Hiller et al. (29) and Waters et al. (15) were 
carried out, respectively, with Holstein and Charolais and Limousine bulls, while in 
our study Aberdeen Angus and Belgian Blue x Fresian heifers were used. Thus a 
variation in SCD gene expression could be related to the choice of breed and sex of the 
cattle used in the experiment. Moreover Keating et al. (31) found that the bovine SCD 
gene promoter was downregulated by oleic acid, which is in line with our findings. 
Overall, the results in the literature are contrasting: for example Sessler et al. (32) 
showed in vitro that mRNA expression for SCD was decreased in a dose- dependent 
manner by addition of n-6 PUFA, linoleic acid and arachidonic acid to a murine cell 
line and also linolenic acid inhibited SCD gene expression in mouse adipocyte cell 
line. 
Consistent with these findings, the work of McGettrick et al. (33) reported that grazing 
cattle supplemented with FO had lesser relative quantities of SCD mRNA in muscle 
and adipose tissue. Dietary effects on SCD gene expression are also mediated by 
effects on  SREBP-1c and PPARs transcription factors and by hormones such as insulin 
and leptin (34). Waters et al. (15) reported that the effect of n-3 PUFA on SCD mRNA 
levels in bovine could be mediated by reduced SREBP-1c gene expression, while 
Biddinger et al (35) reported a reduced SCD gene expression by leptin with an 
independent mechanism of SREBP-1c. Sterol regulatory element-binding proteins 1c 
(SREBP-1c) also positively regulates the expression of genes encoding lipogenic 
enzymes including ACC and FAS (1,2,36,37). PPARγ and SREBP-1c gene expression 
in relation to different supplementation is discussed below. 
Results of ACC gene expression in our study contrast with those of Hiller et al. (19), 
where ACC expression was decreased due to n-3 supplementation. The absence of 
effects on the expression of the other genes in the lipogenesis pathway (∆5D, ∆6D) 
was instead in line with the study of Buchanan et al (28). To our knowledge, this is the 
first study on ELOVL5 gene expression in relation to different dietary supplementation. 
No difference was found, in accordance with the absence of differences in the 
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expression of the genes encoding ∆5D and ∆6D, involved in the FA synthesis pathway 
immediately before and after ELOVL5. 
Regarding group 2) including the genes PPARγ, PPARα, SREBP-1c and STAT5, no 
differences were found among the treatments. SREBPs are transcription factors for 
cholesterol and fatty acid synthesis (36), activating genes required for the synthesis of 
triacylglycerols and phospholipids (38). PPARγ is a key regulator of adipogenesis, 
cellular differentiation, insulin sensitization, atherosclerosis, and cancer (39) and 
promotes lipogenesis and fat storage. PPARα promotes instead β-oxidation in 
conditions of  negative energy balance, (40,41,42).  
Our results were in contrast with our own previous work (15), and that of Herrmann et 
al (43) and Buchanan et al. (28). The first study reported a negative relationship 
between the expression of SREBP-1c and n-3 supplementation. The second study 
reported instead a reduction in PPARγ gene expression due to CLA supplementation. 
Buchanan et al. (28) reported an up-regulation in gene expression of PPARγ in 
finished-forage heifers. However, our results were in line with Hiller et al (29), who 
reported an absence of relationship between SREBP-1c and different dietary 
supplementation in muscle and with Waters et al. (15), who found that n-3 PUFA had 
no effect on PPAR α gene expression.  
Thus the absence of effect on treatments on SREBP-1c, PPARγ and PPARα could be 
related to a lack in sufficient variation in the supplementation, or to the tissue chosen 
for the analysis as suggested in a previous study by Hiller et al. (19).  
PPARγ can activate GLUT4 gene expression as reported by Wu et al. (44). Herrmann 
et al. (43) reported a reduction in PPARγ expression accompanied by an induced 
GLUT4 gene expression after n-3 supplementation. The authors suggested an isomer 
specific influence of CLA on glucose and lipid metabolism that is genotype dependent 
and poorly mediated by PPARγ. In our work, GLUT4 gene expression was not 
different among the treatment groups. This can be explained with the hypothesis 
suggested above by Herrmann et al.(43) or with the absence of effects of n-3:n-6 
PUFA ratio on PPARα and AMPKα gene expressions, that are two of the main factors 
affecting GLUT4 in muscle (45). Moreover no difference in GLUT4 gene expression 
may have occurred due to the diets being isoenergetic as previously reported by 
Duehlmeier et al (46) and Peyron-Caso et al. (47) as only a change in the glucose 
levels in diet or blood could be related to shifts in GLUT4 gene expression. 
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Due to the roles of STAT5 in inflammation and adipogenesis, and the effects of CLA as 
a mediator of inflammation and body fat mass, a possible relationship with CLA 
supplementation was investigated. 
Indeed, STAT5 is involved in signaling pathways for cell proliferation, apoptosis, cell 
differentiation and inflammations (48). It is strictly related to lipid metabolism: an 
activation of the STAT5/PPARγ pathway by GH affects adipogenesis (49). 
However, STAT5 gene expression did not show any difference among the treatments, 
suggesting its involvement in regulating pathways different than those of CLA. 
Regarding group 2, AMPKα, ADIPOQ and GPR43, no relationships were found 
among the expression of these genes and supplementation in the diet. The results were 
in agreement with the findings of Kelly et al (50), who reported an absence of 
supplementation effects on AMPKα gene expression. Moreover, AMPKα could be 
affected by GPR43 and ADIPOQ, thus the absence of an effect on the last gene 
expression could explain the lack in differences in AMPKα. Our findings were 
however in contrast with those of Buchanan et al (28) and Hiller et al (29). Buchanan 
et al (28) reported that a concentrate-finishing diet was related to a decrease in 
ADIPOQ gene expression and Hiller et al. (29) showed  that a n-3 FA intervention 
down-regulated ADFP gene expression. It could therefore be hypothesized that a lack 
of sufficient differences among the diet applied in this study could explain the lack of 
differences in the expression of genes analysed. 
Breed X Oil supplementation 
The differences found in PPARα gene expression between two breeds among the 
treatments were according to the breed skills: AA muscle are known to have greater 
levels of fat while BB has a strong muscular growth and lean meat (27). Indeed AA 
showed a reduction in PPARα expression, possibly related to β-oxidation and lipid 
catabolism, while the opposite occurred for BB. This result also supported the 
hypothesis that the sampling was carried out when a high lipogenesis occurred, so 
when SCD gene expression in AA animals has already decreased. 
ADIPOQ results could be explained by the role of this gene as an enhancer of fatty 
acid β-oxidation and insulin response. Our findings showed that CLA in AA increased 
ADIPOQ gene expression: that could be related to features of the particular breed used 
(i.e., high marbling and intramuscular fat) and to the CLA effects against 
inflammations (c9,t11) and for the reduction of body fat mass (t10,c12) (53, 54).  
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5. Conclusions 
To our knowledge, this is the first study screening a complete set of genes involved in 
CLA metabolism: our study aimed to investigate the effect of breed and of n-3/n-6 FA 
supplementation on the expression of 15 genes. The Aberdeen Angus and Belgian Blue 
breeds were chosen due to their different impetus in maturing and storing fat. The 
breed effect was showed in ACC and SCD gene expression, that were higher in BB 
(P=0,013; P= 0,055), and in FAS expression, that was higher in AA (P=0,007).  
The diet effect on gene expression was found after n-3 FA supplementation that 
showed a positive correlation with FAS and SCD expressions (P=0,006; P=0,074).  
Finally an interaction between breed and dietary n-3:n-6 ratio was reported for PPARα 
(P= 0,006) and ADIPOQ (P=0,055): n-3 FA reduced PPARα expression in AA, while 
it increased the same gene expression in BB. Moreover ADIPOQ gene expression was 
positively correlated in AA and lower in BB with CLA.  
Thus this study highlighted the significance of breed and of alimentary n-3 and n-6 FA 
intervention on the muscle expression of genes related with CLA metabolism. 
However more studies are needed to investigate the underlying mechanisms and the 
effects on the genes not directly involved in CLA synthesis. 
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Figure 1. Genes involved in the CLA pathways.
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Table 1.  Composition of Experimental Rations 
 
 
 
 
Diet 
 
 
  
kg/tonne 
  
 
  
Control concentrate (Winter)1    
 Barley  865 
 
 
Soya   65 
 Molasses  45 
 Min/Vit-1  25a 
    
CLA Concentrate2 
 
Safflower Oil   200 
 Molasses  50 
 Min/Vit   25b 
  Maize meal  725 
    
Omega 3-PUFA Concentrate3 
 
Farm First  915 
 Molasses  51 
 Min/Vit  34 
1CON; 2CLA; 3ω3; a= Standard Grange; b=80,000 IU vitamin E/kg 
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Table 2. Bovine oligonucleotide primers used for qPCR (Reference and Target genes) 
 
Gene Primer sequence 
PCR 
efficiency 
Size 
(bp) 
Accession No. 
ACTβ Forward: GACACCGCAACCAGTTCGCCAT 0.91 194 NM_173979.3 
 Reverse: AGCCTCATCCCCCACGTACGA    
UBIQ Forward: AGATCCAGGATAAGGAAGGCA 1.06 98 NM_174133 
 Reverse: GCTCCACCTCCAGGGTGAT    
RPS18 Forward: ACCAACATCGATGGGCGGCG 1.11 150 NM_001033614.1 
 Reverse: CACACGTTCCACCTCATCCTCGG    
GAPDH Forward: GATTGTCAGCAATGCCTCCT 0.80 144 NM_001034034 
 Reverse: CCATCCACAGTCTTCTGGGT    
ACC Forward: GAGCTGAACCAGCACTCCCGA 0.90 215 NM_174224.2 
 Reverse: TGCAAGCCAGACATGCTGGATCTCA    
∆5D Forward: AGTTCAGGCCCAGGCTGGCT 0.99 164 XM_612398.5 
 Reverse: TGGGCTTGGCATGGTGCTGG    
∆6D   Forward: TGCCAACTGGTGGAACCATCGC 0.83 189 NM_001083444.1 
 Reverse: GGCGGCCCGATCAGGAAGAAGTAC    
FAS Forward: GCCAGCGGGAAGCGTGTGAT 1.19 235 NM_001012669.1 
 Reverse: CGATGGCAGCCTGGCCTACG    
SCD Forward:  CTACAAAGCTCGGCTGCCTCTGC 0.83 202 NM_173959.4 
 Reverse: TTTGACAGCTGGGTGTTTGCGC    
SREBP1c Forward: TGGGCACCGAGGCCAAGTTGAAT 0.93 170 NM_001113302 
 Reverse: TCCACTGCCACAAGCCGACA    
PPAR γ Forward: AGGATGGGGTCCTCATATCC 0.90 121 NM_181024 
 Reverse: GCGTTGAACTTCACAGCAAA    
AMPKα Forward: GTCAAAGTCGGCCAAATGAT 0.80 104 BC_153842 
 Reverse: CCTCCGAACACGCAAATAAT    
ADFP Forward: GTCTGTCCTGGCTGGAGTGGAAGAG 0.94 150 NM: BT029909.1 
 Reverse: TGTTGGACAGGAGGGTGTGGCA    
PPARα Forward: GGTAACCGGAAGGCTACTCC 0.93 111 NM_001034036 
 Reverse: CCTCATTTCCCAAGTCCTGA    
GPR43 Forward: GACGCAGATGCAAAGAAACA 1.07 107 NM: FJ_562212 
 Reverse: CCAGGAACATCCCTAGTCCA    
GLUT4 Forward: ACCTTATGGCCACTCCTCCT 0.86 180 NM_174604 
 Reverse: CTCAGCCAACACCTCAGACA    
ADIPOQ Forward: CCAAGCAGCACAAAGTGAAA 0.79  NM_174742.2 
 Reverse: AGACTGTCCTGGGAACATGG    
ELOVL5 Forward: CGCCACACTTAACAGCTTCA 0.98 174 NM_001046597.1 
 Reverse: AAGGTACACGGCCAGATGAC    
STAT5 B Forward: TGCATCCGCCATATTCTGTA 0.88 137 NM_174617.3 
 Reverse: AGTCGCAGCTCCTCAAATGT    
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Table 3. Effects of breed and ratio on the gene expression in longissimus dorsi muscle of heifers.1 
             
  AAF  BBF  P-value 
Gene  NONE CLA ω3  NONE CLA ω3  B R BxR 
             
             
ACC  1.752 1.657 1.938  2.319 2.130 1.851  0.013 ns ns 
FAS  0.810 0.945 0.973  0.728 0.835 0.900  0.007 0.006 ns 
SCD  2.08 1.72 2.19  2.39 2.01 2.98  0.055 0.074 ns 
∆6D  1.241 1.134 1.265  1.226 1.228 1.210  ns ns ns 
∆5D  2.031 1.763 2.126  2.247 1.991 1.952  ns ns ns 
EVLOVL5  0.731 0.963 0.867  0.913 0.973 0.789  ns ns ns 
ADIPOQ  0.903 1.075 1.015  1.075 0.622 0.978  ns ns 0.055 
GPR43  -0.484 -0.603 -0.272  -0.455 -0.572 -0.443  ns ns ns 
AMPKα  0.972 0.909 0.927  0.922 0.866 0.907  ns ns ns 
SREBP1c  0.926 1.311 0.903  0.972 0.961 1.091  ns ns ns 
PPARγ   1.114 1.107 1.078  1.130 1.179 1.085  ns ns ns 
PPARα  1.097 1.002 0.959  0.994 1.024 1.165  ns ns 0.008 
STAT5  -0.170 -0.114 -0.056  -0.151 -0.204 -0.236  ns ns ns 
ADFP  1.177 1.206 1.238  1.221 1.332 1.152  ns ns ns 
GLUT4  0.869 0.997 1.090  0.992 0.991 1.054  ns ns ns 
1Gene expression values were normalized to the reference gene after adjustment for efficiencies and interplate variation and converted to values 
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relative to the greatest cycle threshold (Ct) within each data set. 
2ns = not significant; NONE = control diet; CLA = diet supplemented with CLA; ω3 = diet supplemented with ω3; B = breed; R = ratio 
3AA = Aberdeen Angus; BB = Belgian Blue. 
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XIV. GENERAL CONCLUSIONS 
 
Due to the healthy properties exerted by the c9,t11 and t10,c12 CLA, these isomers  
could be considered healthy factors available in dairy products and meat from 
ruminants. 
Dairy foods are essential for body metabolism and some components are involved in 
healthy processes: the synergy among CLA, vitamin D and calcium could be effective 
against cancer, in the prevention of atherosclerosis, in body fat mass reduction and 
insulin resistance control. 
From our study on CLA content in Italian foods, a higher content in cheese than in 
meat was reported. Therefore the consumption of milk and its derivatives should be 
encouraged to improve daily CLA intake in humans, taking care of the implications in 
saturated saturated fatty acid intake, and the feeding straegies should be improved to 
enhance the CLA content in meat. 
Comparing the c9,t11 and t10,c12 isomer contents found in our work with data from 
other countries, some differences were found, due to the different feeding strategies 
and food processing methods. 
That confirmed that CLA food data produced on a National scale were necessary to 
implement the knowledge concerning the CLA intake needed for epidemiological 
studies. 
As a matter of fact our studies showed that the CLA intake in Italy could not reach the 
proposed needed amount of 0.8-3 g/day reported by Parish et al. (2003) to exert the 
health benefits in human. 
Thus more strategies are needed to improve the CLA amount in foods, particularly 
with genetic approaches. 
A large number of genetic studies showed the undergoing mechanisms involved in 
CLA synthesis. In our research some genes involved in CLA synthesis were found to 
be affected by CLA or ω3 supplementation within the diet, and the CLA synthesis in 
tissues was improved. 
Thus a nutri-genomic approach is needed to identify the best and easiest strategies 
enhancing the amount of CLA isomers in foods. 
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More information on these issue could allow the farmers and the LRT to provide foods 
with higher nutritional values, thus improving consumers satisfaction and public 
health.
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